1.遗传性癫痫伴热性惊厥附加症的分子遗传学研究 2.中文版青少年癫痫患者生活质量问卷信度及效度检验
摘要
全面性癫痫伴热性惊厥附加症(GEFS+)的概念提出已超过10年,被国际抗癫痫联盟(ILAE)2001年癫痫及癫痫综合征诊断草案列为有待进一步明确的癫痫综合征。随着分子遗传学研究的不断深入,GEFS+概念的提出者Sheffer将其更名为遗传性癫痫伴热性惊厥附加症(GeEFS+),以覆盖更多FS相关的遗传性癫痫。概念的扩大化虽然解决了命名上存在的矛盾,但遗传异质性导致的表型和基因型间不确定的对应关系仍困扰着研究者们。
【目的】通过对三个北方GEFS+家系的基因定位研究,结合对GeEFS+患者突变筛查阳性率的统计及GEFS+患者表型与基因型关系的分析,探讨GeEFS+的可能分子遗传机制及可行的研究方法,强调继续GeEFS+分子遗传学研究对癫痫病因学、癫痫综合征分类学及临床实践的意义。
【方法】第一部分,采用共享等位基因分析及连锁分析对收集到的田氏及柴氏GEFS+家系进行5个候选基因及4个基因座的排查及定位。按照θ=0时,Lod值≥2提示连锁,≤-2排除连锁的标准,对所有STR进行筛选。用Cylliric2.0软件对可能连锁区域进行精确定位,构建单体型,之后对区域内候选基因编码外显子、剪接位点及启动子测序,寻找突变。邸氏家系只通过等位基因共享对5个候选基因进行排查。第二部分,首先,搜索Pubmed及万方数据库,选择与FS、GEFS+、PEFS+、家族性TLE伴FS相关的文献;其次,汇总3个常见候选基因SCN1B、SCN1A、GABRG2突变及表型的详细信息;第三,计算GeEFS+中SCN1B、SCN1A、GABRG2、SCN2A及GABRD基因突变筛查阳性率;第四,比较携带SCN1B、SCN1A、GABRG2突变GEFS+家系之间、携带突变与未发现突变GEFS+家系之间表型的差异。
【结果】第一部分显示,田氏家系在5q34区域D5S422处得到最大LOD值2.043,根据单体型重建,提示该家系的致病位点与D5S820-D5S422间6Mb的区域存在连锁关系。对GABRG2、GABRA1编码外显子、剪接位点及启动子测序,结果未见突变,发现6个SNP,分别为rs11135176、rs211037(GABRG2)和rs11575999、rs41275339、rs11576004、rs2279020(GABRA1)。rs11575999、rs41275339、rs11576004未与家系共分离,rs211037与GEFS+无关联。柴氏及邸氏与所有候选基因及基因座无肯定连锁关系。
第二部分显示,有SCN1A突变的GEFS+家系表型特点更鲜明,表现为:FS+多于FS,表型分布更丰富,外显率更高,FS起病早且孤立发作罕有,突变的部位、性质及对离子通道功能的影响均与表型特点有关。GABRG2家系FS患者明显多于FS+患者,部分性发作罕有,苯二氮卓作用位点的突变与失神发作密切相关。SCN1B的FS及FS+百分比更接近SCN1A,但没有后者表型丰富。没有找到突变的家系FS多而FS+少,虽然表型较丰富,但缺乏严重表型,如MAE和SMEI。
【结论】虽然大多数常染色体显性FS家系、表型单一且缺乏严重表型的GEFS+家系将难以找到致病突变,但加强GeEFS分子遗传学的研究并非没有意义,这很可能对表型严重的癫痫或难治性癫痫分子机制的研究有促进作用。本研究扩大了候选基因排查的范围,优化了微卫星遗传标记,并在常规外显子测序的基础上,增加了候选基因启动子测序、SNP的共分离分析及基于家系的关联分析,这为进一步的基因定位研究打下了坚实的基础。
[目的]青少年癫痫患者的生活质量研究开展较晚,目前国内还缺乏相应的调查问卷。由美国耶鲁大学医学院Cramer设计的QOLIE-AD-48是目前唯一专门用于青少年癫痫患者的自陈式生活质量调查问卷,具有良好的信度、效度及敏感度,已被翻译为多种语言版本,并逐步应用于临床研究。本研究的目的在于将英文版QOLIE-AD-48翻译为中文,并检验其信度、效度及敏感度,为临床研究提供一个良好的测量工具。
【方法】根据欧洲癌症研究及治疗机构(EORTC)生活质量小组关于量表翻译过程的指南,将QOLIE-AD-48翻译成中文。总样本量的选择及测量指标验证的最低期望值根据欧洲生活质量评估小组指南。用PASS2008软件估计研究所需总样本量及重测信度所需样本量。进入心理测量学特性分析过程患者的入选标准为:1)活动性癫痫(2年内至少1次发作);2)癫痫病程超过2年;3)过去的4个月内AEDs无变化;4)正常上学,具备阅读及书写中文能力。有脑外科手术史、同时应用其他中枢神经系统药物或者有进行性神经或精神疾病的青少年患者被排除。参加重测信度分析的患者要求在两次测验间的健康及社会状态无变化。检验的信度指标包括内部一致信度(Cronbach'sα系数)及重测信度(组内相关系数,intraclass correlationcoefecient,ICC),效度指标包括聚合及判别效度、结构效度。敏感度分析通过比较不同发作严重程度总分的差异是否显著来评价。
【结果】在OOLIE-AD-48翻译为中文的过程中碰到的主要问题是对动词时态及其准确含义的理解。另外,跨文化的问题也比较突出。PASS2008软件估计总样本量不低于105例,重测信度样本量不低于43例。从2007年8月至2009年3月,总计145例患者参加了第一次QOLIE-AD-48测验,其中60例在14-30天内进行第二次测验,45例符合重测信度统计的入选标准。75.9%的受试者完成了所有题目,完成时间平均为16分钟(范围10-25分钟)。分量表的平均分数在25.4到91.9分之间,总分为67.5。“对待癫痫的态度”分量表(20.0%)有明显的地板效应,“躯体功能”(20.7%)及“学校表现”分量表(53.8%)有明显的天花板效应。总分无天花板及地板效应。聚合/判别效度结果显示,分量表内的每道题目与所在分量表的相关系数在0.4以上,每一题目与所在分量表的相关性高于其他分量表。此外,QOLIE-AD-48总分与PedsQL总分显著相关。主轴因子分析显示没有二级因子产生,所有的分量表与总分显著相关(r=0.37-0.91)。总分内部一致信度为0.93,分量表在0.60-0.91之间(表5),PedsQL的Cronbach'sα系数为0.92。QOLIE-AD-48的总分重测信度为0.76。总分随发作严重程度的增加而显著下降,显示敏感度良好。
【结论】总而言之,QOLIE-AD-48中文版的翻译过程经过反复斟酌,测验结果显示基本满足HROOL量表所需的心理测量学特性标准,具有良好的效度、信度及敏感度。因此,该量表完全可以胜任中国青少年癫痫患者HRQOL研究之需。毫无疑问,未来的临床研究必将会从该量表的应用中受益。
The name of generalized epilepsy with febrile seizures plus(GEFS+) has been used for more than ten years and was listed as "syndromes in development" by the 2001 ILAE Proposed Diagnostic Scheme for People with Epileptic Seizures and with Epilepsy. With the development of molecular genetics,Scheffer recently proposed changing the name of GEFS+ to "genetic epilepsy with febrile seizures plus" from "generalized epilepsy with febrile seizures plus".This was because although generalized epilepsies predominate in GEFS+ families,focal or partial epilepsies are well recognized with and without preceding FS.The problematic name was changed,but the uncertain relationship between the phenotype and the genotype still puzzles the researchers.
Objective We mapped the genes of three GEFS+ families from the north of China, calculate mutation rate of GeEFS+,and analyze the relationship between the phenotype and the genotype of GEFS+ in order to explore the possible molecular mechanisms of GeEFS+ and the feasible study methods。We emphasize that further study on molecular genetic mechanisms is very important to epilepsy etiology,classification of epilepsy syndromes and clinical practice.
Methods In the first part,we used allele sharing and linkage analysis to genotype the family members in Family Tian and Family Chai with microsatellites for reported 5 candidate genes and 4 candidate loci for GEFS+ and FS.We screened all STRs according to the evaluation criterion of LOD score(≥2:hint of linkage atθ=0;≤-2:hint of no linkage atθ=0).The Cylliric2.0 software was used to reconstruct haplotype for fine mapping.Then,a mutation search by means of direct sequencing was performed in the coding exons,flanking splice sites and promotor of two genes(GABRG2 and GABRA1). Only allele sharing was performed to screen 5 candidate genes in Family Di.In the second part,first,the literatures retrieval was performed at Pubmed and Wanfang database.The articles on FS、GEFS+、PEFS+ and familial TLE with febrile seizures were included.Second,the information on characteristics of mutations in three genes(SCN1B, SCN1A and GABRG2) was collected.Third,mutation rate of SCN1B,SCN1A, GABRG2,SCN2A and GABRD in GeEFS+ was calculated.Fourth,the phenotypes among the families with mutations in three genes(SCN1B,SCN1A and GABRG2) and between the families with and without mutations were compared.
Results Family Tian had a maximum LOD score(Zmax=2.043) atθ=0 for D5S422.In this family,linkage to 6Mb region between D5S820 and D5S422 could be possible based on haplotype analysis.Direct sequencing in GABRG2 and GABRA1 was performed,and no causal mutations were found.Six SNPs were detected,including rs11135176 and rs211037 in GABRG2 and rs11575999、rs41275339、rs11576004 and rs2279020 in GABRA1.Co-segregation of rs11575999、rs41275339 and rs11576004 with phenotype was excluded and association on rs211037 with phenotype was not found.Linkage to all candidate genes and loci could be excluded in Family Chai and Di.
The families with mutation in SCN1A had more specific characters in phenotype: FS+ much more than FS,wide phenotype distribution,higher penetrance,early onset and rare single FS.Location and type of the mutations as well as effect of the mutations on ion Channel were associated with phenotype.In the families with mutation in GABRG2, the patients with FS were more than those with FS+,partial seizures were rare,and the mutations in benzodiazepin binding pocket were associated with absence seizures.In the families with mutations in SCN1B,the patients with FS and FS+ were similar to those with mutations in SCN1A,but the quantity of phenotype was not as much as the latter. FS was more oftern than FS+ in the families in which mutations could not be found. Although the quantity of phenotype was much,severe phenotype was not found,such as MAE and SMEI..
Conclusion Although it is very difficult to find the causal mutations in most of the Autosome dominant FS families and GEFS+ with simple phenotype and without severe phenotype,further study on molecular genetics in GeEFS is by no means nonsignificant, which could facilitate study on molecular mechanisms of epilepsies with severe phenotype or refractory epilepsies.We supplemented the candidate genes and loci, optimized the genetic markers,performed direct senquencing in promoters, co-segregation analysis in three SNPs besides sequencing in the coding exons and family-based association tests in one SNP,which established a substantial foundation for further gene localization.
Research on health-related quality of life(HRQOL) in adolescents with epilepsy began relatively late in China,even though significant advances had been made in Western societies.One reason for this was the unavailability of valid measures for measuring and evaluating adolescents' HRQOL in China.The Quality of Life in Epilepsy Inventory for Adolescents(QOLIE-AD-48) is the most frequently recommended questionnaire for measuring HRQOL in youths with epilepsy and has been used in different studies to date.The QOLIE-AD 48 has been validated in several languages,including Spanish,Serbian,and Brazilian Portuguese recently,and these translations have been shown to be as specific and sensitive as the original version.
Objective The aim of this study was to translate into Chinese the Quality of Life in Epilepsy Inventory for Adolescents(QOLIE-AD-48) and to evaluate its psychometric properties.
Methods The QOLIE-AD-48 was translated according to the procedure of the European Organization for Research and Treatment of Cancer(EORTC) Quality of Life Group. After a multistage translation and cultural adaptation,the final Chinese version was administered to 145 adolescents with epilepsy to evaluate its validity and reliability.The inclusion criteria were:(1) active epilepsy(i.e.,at least one seizure in the last 2 years); (2) epilepsy duration longer than 2 years;(3) no change in antiepileptic drug regimens in the past 4 months;(4) regular school attendance with ability to read and write Chinese.Adolescents who had had brain surgery,used a concomitant medication with central nervous system effects,or had progressive neurological or psychiatric illness were not considered eligible for the study.Test-retest analysis was administered to 45 adolescents without significant changes in health and social status during a two-four weeks' interval between test and retest.Interitem correlations,correlations with the Pediatric Quality of Life Inventory(PedsQL),internal consistency,test-retest reliability and sensitivity were examined.
Results The main translational problems encountered in developing the Chinese QOLIE-AD-48 were due to discrepancies in verbs form and exact meanings,which involved mainly the content of some items.Cross-cultural problems were also difficult to he solved.The acceptability,as well as the feasibility,of the Chinese version appeared satisfactory,considering that 75.9%of the adolescents completed the entire instrument within 10-25 min.Mean total score was 67.5,and all subscales contributed significantly to the summary measure.Considering the validity of the translation,each item correlated
Research on health-related quality of life(HRQOL) in adolescents with epilepsy began relatively late in China,even though significant advances had been made in Western societies.One reason for this was the unavailability of valid measures for measuring and evaluating adolescents' HRQOL in China.The Quality of Life in Epilepsy Inventory for Adolescents(QOLIE-AD-48) is the most frequently recommended questionnaire for measuring HRQOL in youths with epilepsy and has been used in different studies to date.The QOLIE-AD 48 has been validated in several languages,including Spanish,Serbian,and Brazilian Portuguese recently,and these translations have been shown to be as specific and sensitive as the original version.
Objective The aim of this study was to translate into Chinese the Quality of Life in Epilepsy Inventory for Adolescents(QOLIE-AD-48) and to evaluate its psychometric properties.
Methods The QOLIE-AD-48 was translated according to the procedure of the European Organization for Research and Treatment of Cancer(EORTC) Quality of Life Group. After a multistage translation and cultural adaptation,the final Chinese version was administered to 145 adolescents with epilepsy to evaluate its validity and reliability.The inclusion criteria were:(1) active epilepsy(i.e.,at least one seizure in the last 2 years); (2) epilepsy duration longer than 2 years;(3) no change in antiepileptic drug regimens in the past 4 months;(4) regular school attendance with ability to read and write Chinese.Adolescents who had had brain surgery,used a concomitant medication with central nervous system effects,or had progressive neurological or psychiatric illness were not considered eligible for the study.Test-retest analysis was administered to 45 adolescents without significant changes in health and social status during a two-four weeks' interval between test and retest.Interitem correlations,correlations with the Pediatric Quality of Life Inventory(PedsQL),internal consistency,test-retest reliability and sensitivity were examined.
Results The main translational problems encountered in developing the Chinese QOLIE-AD-48 were due to discrepancies in verbs form and exact meanings,which involved mainly the content of some items.Cross-cultural problems were also difficult to he solved.The acceptability,as well as the feasibility,of the Chinese version appeared satisfactory,considering that 75.9%of the adolescents completed the entire instrument within 10-25 min.Mean total score was 67.5,and all subscales contributed significantly to the summary measure.Considering the validity of the translation,each item correlated
【目的】通过对三个北方GEFS+家系的基因定位研究,结合对GeEFS+患者突变筛查阳性率的统计及GEFS+患者表型与基因型关系的分析,探讨GeEFS+的可能分子遗传机制及可行的研究方法,强调继续GeEFS+分子遗传学研究对癫痫病因学、癫痫综合征分类学及临床实践的意义。
【方法】第一部分,采用共享等位基因分析及连锁分析对收集到的田氏及柴氏GEFS+家系进行5个候选基因及4个基因座的排查及定位。按照θ=0时,Lod值≥2提示连锁,≤-2排除连锁的标准,对所有STR进行筛选。用Cylliric2.0软件对可能连锁区域进行精确定位,构建单体型,之后对区域内候选基因编码外显子、剪接位点及启动子测序,寻找突变。邸氏家系只通过等位基因共享对5个候选基因进行排查。第二部分,首先,搜索Pubmed及万方数据库,选择与FS、GEFS+、PEFS+、家族性TLE伴FS相关的文献;其次,汇总3个常见候选基因SCN1B、SCN1A、GABRG2突变及表型的详细信息;第三,计算GeEFS+中SCN1B、SCN1A、GABRG2、SCN2A及GABRD基因突变筛查阳性率;第四,比较携带SCN1B、SCN1A、GABRG2突变GEFS+家系之间、携带突变与未发现突变GEFS+家系之间表型的差异。
【结果】第一部分显示,田氏家系在5q34区域D5S422处得到最大LOD值2.043,根据单体型重建,提示该家系的致病位点与D5S820-D5S422间6Mb的区域存在连锁关系。对GABRG2、GABRA1编码外显子、剪接位点及启动子测序,结果未见突变,发现6个SNP,分别为rs11135176、rs211037(GABRG2)和rs11575999、rs41275339、rs11576004、rs2279020(GABRA1)。rs11575999、rs41275339、rs11576004未与家系共分离,rs211037与GEFS+无关联。柴氏及邸氏与所有候选基因及基因座无肯定连锁关系。
第二部分显示,有SCN1A突变的GEFS+家系表型特点更鲜明,表现为:FS+多于FS,表型分布更丰富,外显率更高,FS起病早且孤立发作罕有,突变的部位、性质及对离子通道功能的影响均与表型特点有关。GABRG2家系FS患者明显多于FS+患者,部分性发作罕有,苯二氮卓作用位点的突变与失神发作密切相关。SCN1B的FS及FS+百分比更接近SCN1A,但没有后者表型丰富。没有找到突变的家系FS多而FS+少,虽然表型较丰富,但缺乏严重表型,如MAE和SMEI。
【结论】虽然大多数常染色体显性FS家系、表型单一且缺乏严重表型的GEFS+家系将难以找到致病突变,但加强GeEFS分子遗传学的研究并非没有意义,这很可能对表型严重的癫痫或难治性癫痫分子机制的研究有促进作用。本研究扩大了候选基因排查的范围,优化了微卫星遗传标记,并在常规外显子测序的基础上,增加了候选基因启动子测序、SNP的共分离分析及基于家系的关联分析,这为进一步的基因定位研究打下了坚实的基础。
[目的]青少年癫痫患者的生活质量研究开展较晚,目前国内还缺乏相应的调查问卷。由美国耶鲁大学医学院Cramer设计的QOLIE-AD-48是目前唯一专门用于青少年癫痫患者的自陈式生活质量调查问卷,具有良好的信度、效度及敏感度,已被翻译为多种语言版本,并逐步应用于临床研究。本研究的目的在于将英文版QOLIE-AD-48翻译为中文,并检验其信度、效度及敏感度,为临床研究提供一个良好的测量工具。
【方法】根据欧洲癌症研究及治疗机构(EORTC)生活质量小组关于量表翻译过程的指南,将QOLIE-AD-48翻译成中文。总样本量的选择及测量指标验证的最低期望值根据欧洲生活质量评估小组指南。用PASS2008软件估计研究所需总样本量及重测信度所需样本量。进入心理测量学特性分析过程患者的入选标准为:1)活动性癫痫(2年内至少1次发作);2)癫痫病程超过2年;3)过去的4个月内AEDs无变化;4)正常上学,具备阅读及书写中文能力。有脑外科手术史、同时应用其他中枢神经系统药物或者有进行性神经或精神疾病的青少年患者被排除。参加重测信度分析的患者要求在两次测验间的健康及社会状态无变化。检验的信度指标包括内部一致信度(Cronbach'sα系数)及重测信度(组内相关系数,intraclass correlationcoefecient,ICC),效度指标包括聚合及判别效度、结构效度。敏感度分析通过比较不同发作严重程度总分的差异是否显著来评价。
【结果】在OOLIE-AD-48翻译为中文的过程中碰到的主要问题是对动词时态及其准确含义的理解。另外,跨文化的问题也比较突出。PASS2008软件估计总样本量不低于105例,重测信度样本量不低于43例。从2007年8月至2009年3月,总计145例患者参加了第一次QOLIE-AD-48测验,其中60例在14-30天内进行第二次测验,45例符合重测信度统计的入选标准。75.9%的受试者完成了所有题目,完成时间平均为16分钟(范围10-25分钟)。分量表的平均分数在25.4到91.9分之间,总分为67.5。“对待癫痫的态度”分量表(20.0%)有明显的地板效应,“躯体功能”(20.7%)及“学校表现”分量表(53.8%)有明显的天花板效应。总分无天花板及地板效应。聚合/判别效度结果显示,分量表内的每道题目与所在分量表的相关系数在0.4以上,每一题目与所在分量表的相关性高于其他分量表。此外,QOLIE-AD-48总分与PedsQL总分显著相关。主轴因子分析显示没有二级因子产生,所有的分量表与总分显著相关(r=0.37-0.91)。总分内部一致信度为0.93,分量表在0.60-0.91之间(表5),PedsQL的Cronbach'sα系数为0.92。QOLIE-AD-48的总分重测信度为0.76。总分随发作严重程度的增加而显著下降,显示敏感度良好。
【结论】总而言之,QOLIE-AD-48中文版的翻译过程经过反复斟酌,测验结果显示基本满足HROOL量表所需的心理测量学特性标准,具有良好的效度、信度及敏感度。因此,该量表完全可以胜任中国青少年癫痫患者HRQOL研究之需。毫无疑问,未来的临床研究必将会从该量表的应用中受益。
The name of generalized epilepsy with febrile seizures plus(GEFS+) has been used for more than ten years and was listed as "syndromes in development" by the 2001 ILAE Proposed Diagnostic Scheme for People with Epileptic Seizures and with Epilepsy. With the development of molecular genetics,Scheffer recently proposed changing the name of GEFS+ to "genetic epilepsy with febrile seizures plus" from "generalized epilepsy with febrile seizures plus".This was because although generalized epilepsies predominate in GEFS+ families,focal or partial epilepsies are well recognized with and without preceding FS.The problematic name was changed,but the uncertain relationship between the phenotype and the genotype still puzzles the researchers.
Objective We mapped the genes of three GEFS+ families from the north of China, calculate mutation rate of GeEFS+,and analyze the relationship between the phenotype and the genotype of GEFS+ in order to explore the possible molecular mechanisms of GeEFS+ and the feasible study methods。We emphasize that further study on molecular genetic mechanisms is very important to epilepsy etiology,classification of epilepsy syndromes and clinical practice.
Methods In the first part,we used allele sharing and linkage analysis to genotype the family members in Family Tian and Family Chai with microsatellites for reported 5 candidate genes and 4 candidate loci for GEFS+ and FS.We screened all STRs according to the evaluation criterion of LOD score(≥2:hint of linkage atθ=0;≤-2:hint of no linkage atθ=0).The Cylliric2.0 software was used to reconstruct haplotype for fine mapping.Then,a mutation search by means of direct sequencing was performed in the coding exons,flanking splice sites and promotor of two genes(GABRG2 and GABRA1). Only allele sharing was performed to screen 5 candidate genes in Family Di.In the second part,first,the literatures retrieval was performed at Pubmed and Wanfang database.The articles on FS、GEFS+、PEFS+ and familial TLE with febrile seizures were included.Second,the information on characteristics of mutations in three genes(SCN1B, SCN1A and GABRG2) was collected.Third,mutation rate of SCN1B,SCN1A, GABRG2,SCN2A and GABRD in GeEFS+ was calculated.Fourth,the phenotypes among the families with mutations in three genes(SCN1B,SCN1A and GABRG2) and between the families with and without mutations were compared.
Results Family Tian had a maximum LOD score(Zmax=2.043) atθ=0 for D5S422.In this family,linkage to 6Mb region between D5S820 and D5S422 could be possible based on haplotype analysis.Direct sequencing in GABRG2 and GABRA1 was performed,and no causal mutations were found.Six SNPs were detected,including rs11135176 and rs211037 in GABRG2 and rs11575999、rs41275339、rs11576004 and rs2279020 in GABRA1.Co-segregation of rs11575999、rs41275339 and rs11576004 with phenotype was excluded and association on rs211037 with phenotype was not found.Linkage to all candidate genes and loci could be excluded in Family Chai and Di.
The families with mutation in SCN1A had more specific characters in phenotype: FS+ much more than FS,wide phenotype distribution,higher penetrance,early onset and rare single FS.Location and type of the mutations as well as effect of the mutations on ion Channel were associated with phenotype.In the families with mutation in GABRG2, the patients with FS were more than those with FS+,partial seizures were rare,and the mutations in benzodiazepin binding pocket were associated with absence seizures.In the families with mutations in SCN1B,the patients with FS and FS+ were similar to those with mutations in SCN1A,but the quantity of phenotype was not as much as the latter. FS was more oftern than FS+ in the families in which mutations could not be found. Although the quantity of phenotype was much,severe phenotype was not found,such as MAE and SMEI..
Conclusion Although it is very difficult to find the causal mutations in most of the Autosome dominant FS families and GEFS+ with simple phenotype and without severe phenotype,further study on molecular genetics in GeEFS is by no means nonsignificant, which could facilitate study on molecular mechanisms of epilepsies with severe phenotype or refractory epilepsies.We supplemented the candidate genes and loci, optimized the genetic markers,performed direct senquencing in promoters, co-segregation analysis in three SNPs besides sequencing in the coding exons and family-based association tests in one SNP,which established a substantial foundation for further gene localization.
Research on health-related quality of life(HRQOL) in adolescents with epilepsy began relatively late in China,even though significant advances had been made in Western societies.One reason for this was the unavailability of valid measures for measuring and evaluating adolescents' HRQOL in China.The Quality of Life in Epilepsy Inventory for Adolescents(QOLIE-AD-48) is the most frequently recommended questionnaire for measuring HRQOL in youths with epilepsy and has been used in different studies to date.The QOLIE-AD 48 has been validated in several languages,including Spanish,Serbian,and Brazilian Portuguese recently,and these translations have been shown to be as specific and sensitive as the original version.
Objective The aim of this study was to translate into Chinese the Quality of Life in Epilepsy Inventory for Adolescents(QOLIE-AD-48) and to evaluate its psychometric properties.
Methods The QOLIE-AD-48 was translated according to the procedure of the European Organization for Research and Treatment of Cancer(EORTC) Quality of Life Group. After a multistage translation and cultural adaptation,the final Chinese version was administered to 145 adolescents with epilepsy to evaluate its validity and reliability.The inclusion criteria were:(1) active epilepsy(i.e.,at least one seizure in the last 2 years); (2) epilepsy duration longer than 2 years;(3) no change in antiepileptic drug regimens in the past 4 months;(4) regular school attendance with ability to read and write Chinese.Adolescents who had had brain surgery,used a concomitant medication with central nervous system effects,or had progressive neurological or psychiatric illness were not considered eligible for the study.Test-retest analysis was administered to 45 adolescents without significant changes in health and social status during a two-four weeks' interval between test and retest.Interitem correlations,correlations with the Pediatric Quality of Life Inventory(PedsQL),internal consistency,test-retest reliability and sensitivity were examined.
Results The main translational problems encountered in developing the Chinese QOLIE-AD-48 were due to discrepancies in verbs form and exact meanings,which involved mainly the content of some items.Cross-cultural problems were also difficult to he solved.The acceptability,as well as the feasibility,of the Chinese version appeared satisfactory,considering that 75.9%of the adolescents completed the entire instrument within 10-25 min.Mean total score was 67.5,and all subscales contributed significantly to the summary measure.Considering the validity of the translation,each item correlated
Research on health-related quality of life(HRQOL) in adolescents with epilepsy began relatively late in China,even though significant advances had been made in Western societies.One reason for this was the unavailability of valid measures for measuring and evaluating adolescents' HRQOL in China.The Quality of Life in Epilepsy Inventory for Adolescents(QOLIE-AD-48) is the most frequently recommended questionnaire for measuring HRQOL in youths with epilepsy and has been used in different studies to date.The QOLIE-AD 48 has been validated in several languages,including Spanish,Serbian,and Brazilian Portuguese recently,and these translations have been shown to be as specific and sensitive as the original version.
Objective The aim of this study was to translate into Chinese the Quality of Life in Epilepsy Inventory for Adolescents(QOLIE-AD-48) and to evaluate its psychometric properties.
Methods The QOLIE-AD-48 was translated according to the procedure of the European Organization for Research and Treatment of Cancer(EORTC) Quality of Life Group. After a multistage translation and cultural adaptation,the final Chinese version was administered to 145 adolescents with epilepsy to evaluate its validity and reliability.The inclusion criteria were:(1) active epilepsy(i.e.,at least one seizure in the last 2 years); (2) epilepsy duration longer than 2 years;(3) no change in antiepileptic drug regimens in the past 4 months;(4) regular school attendance with ability to read and write Chinese.Adolescents who had had brain surgery,used a concomitant medication with central nervous system effects,or had progressive neurological or psychiatric illness were not considered eligible for the study.Test-retest analysis was administered to 45 adolescents without significant changes in health and social status during a two-four weeks' interval between test and retest.Interitem correlations,correlations with the Pediatric Quality of Life Inventory(PedsQL),internal consistency,test-retest reliability and sensitivity were examined.
Results The main translational problems encountered in developing the Chinese QOLIE-AD-48 were due to discrepancies in verbs form and exact meanings,which involved mainly the content of some items.Cross-cultural problems were also difficult to he solved.The acceptability,as well as the feasibility,of the Chinese version appeared satisfactory,considering that 75.9%of the adolescents completed the entire instrument within 10-25 min.Mean total score was 67.5,and all subscales contributed significantly to the summary measure.Considering the validity of the translation,each item correlated
引文
1 Scheffer I,Berkovic S.Generalized(genetic) epilepsy with febrile seizures plus.In:Engel JJ,Pedley T,editors.Epilepsy:a comprehensive textbook.Philadelphia:Lippincott,Williams & Wilkins;2008.p.2553-8.
2 Ingrid E.Scheffer,Yue-Hua Zhang,Floor E.Jansen,et al.Dravet syndrome or genetic(generalized) epilepsy with febrile seizures plus? Brain & Development.2009 Feb 7.[Epub ahead of print]
3 Scheffer IE,Berkovic SF.Generalised epilepsy with febrile seizures plus-a genetic disorder with heterogeneous clinical phenotypes.Brain 1997;120,479-490.
4 Engel Jr.J.Report of the ILAE Classification Core Group.Epilepsia,2006;47:1558-68.
5 席妹景,黄希顺,魏建科等.全面性癫痫伴热性惊厥附加症6家系SCNlB基因突变筛查.[J]实用儿科临床杂志,2007,22:436-440.
6 常秀红,黄希顺,魏建等.GABRG2在全面性癫痫伴热性惊厥附加症中的研究.[J]神经疾病与精神卫生,2007,7:89-93.
7 周水珍,宋义清,陈超等.全面性癫痫伴热性惊厥附加症的临床与分子遗传学研究.[J]中华神经科杂志2007,40:465-470.
8 张守山,黄希顺,王家勤等.全面性癫痫伴热性惊厥附加症家系GABRB2基因测序研究.[J]实用儿科临床杂志,2006,21:30-31.
9 林华,王玉平,王梦阳等.全面性癫痫伴热性惊厥附加症家系致病基因的连锁定位和突变分析.[J]中华医学杂志,2008,88:3177-3188.
10 魏建科,黄希顺,尹景岗.全身性癫痫伴热性惊厥附加症家系GABRA1基因测序分析.[J]中国现代医学杂志,2006,16:21-25.
11 魏建科,魏华,黄希顺.全身性癫痫伴热性惊厥附加症2个家系致病基因GABRG2测序分析.[J]郑州大学学报,2006,41:1049-1052.
12 LIU X,DENG Y,LIAO P,et al.The clinical and genetic features of generalized epilepsy with febrile seizure plus(GEFS+) in Chinese families.Neurology Asia 2004;9(Supplement 1):91.
13 Sun H,Zhang Y,Liang J,et al.SCNIA,SCN1B,and GABRG2 gene mutation analysis in Chinese families with generalized epilepsy with febrile seizures plus.J Hum Genet 2008;53:769-74.
14 Hindocha N,Nabbout R,Elmslie F,et al.A case report of a family with overlapping features of autosomal dominant febrile seizures and GEFS+.Epilepsia 2008 Nov 19.[Epub ahead of print].
15 Liao WP,Shi YW,Qin B.Partial epilepsy with febrile seizure plus:A subtype of GEFS+ or SME? Neurology Asia 2007;12(Supplement 1):78-79.
16 陈俐,石奕武,邓维意.部分性痫伴热性惊厥附加症家系中的SCNlA基因嵌合突变.中华神经科杂志2008;41:580-584.
17 Baulac S,Huberfeld G,Gourfinkel Anl,et al.First Genetic evidence of GABA(A)receptor dysfunction in epilepsy:a mutation in the gamma2 subunit gene.Nat Genet2001;28:46-48.
18 Harkin LA,Bowser DN,Dibbens LM,et al.Truncation of the GABAA receptor c2-subunit in a family with generalized epilepsy with febrile seizures plus.Am J Hum Genet 2002;70:530-536.
19 Deng H,Xie Wa,Le W,et al.Genetic analysis of the GABRA1 gene in patients with essential tremor.Neuroscience Letters 2006;401:16-19.
20 王铮.单基因遗传病的突变筛查与分子遗传学分析[D].北京:北京协和医学院中国医学科学院,2008:22-24.
21 Lathrop GM,Lalouel JM Easy calculations of LOD scores and genetic risks on small computers.Am J Hum Genet 1984;36:460-465.
22 LeeY,LeeY,Kim B.ECgene:an alternative splicing database update.Nucleic Acids Research 2007,35:99-103.
23 Bhatti P,Church DM,Rutter JL.Candidate Single Nucleotide Polymorphism Selection using Publicly Available Tools:A Guide for Epidemiologists Am J Epidemiol 2006;164:794-804.
24 Kast C,WangM,Whiteway M.The ERK/MAPK Pathway Regulates the Activity of the Human Tissue Factor Pathway Inhibitor-2 Promoter.J Biol Chem 2003;278:6787-6794.
25 林华.全面性癫痫伴热性惊厥附加症家系致病基因定位及克隆研究[D].北京:北京协和医学院 中国医学科学院,2007:37-47.
26 Singh R,Scheffer IE,Crossland K,et al.Generalized epilepsy with febrile seizures plus:a common childhood-onset genetic epilepsy syndrome.Ann Neurol 1999;45:75-81.
27 Lerche H,Weber YG,Bater H,et al.Generalized epilepsy with febrile seizures plus:further heterogeneity in a large family.Neurology 2001;57:1191-1198.
28 人类分子遗传学
29 马厚勋,牛永红,李章勇等.等位基因特异性引物PCR技术及其应用研究.生物技术,2005,15:15-18.
30 周晨慧,彭惠民.双向等位特异PCR技术及其在单核苷酸多态性研究中的应用.重庆医科大学学报2006,31:658-661.
31 Wingender,E.,Dietze,P.,Karas,H.and Knu(?)ppel,R.(1996) TRANSFAC:a database on transcription factors and their DNA binding sites.Nucleic Acids Res 24;238-241.
32 Chekmenev DS,Haid C,.Kel A E.P-Match:transcription factor binding site search by combining patterns and weight matrices.Nucleic Acids Research 2005;33,Web Server issue.
33 Ponomarenko JV,Merkulova TI,Orlova GV.rSNP_Guide,a database system for analysis of transcription factor binding to DNA with variations:application to genome annotation.Nucleic Acids Research 2003;31:118-121.
34 CossettelP,Liu L,Briseboisl K,et al.Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy.nature genetics 2002;31:184-9.
35 A Mutation in the GABAA Receptor _1-Subunit Is Associated with Absence Epilepsy Maljevic S,Krampfl K,Cobilanschi J.Ann Neurol 2006;59:983-987.
36 Spielman RS,McGinnis RE,Ewens WJ.Transmission test for linkage disequilibrium:the insulin gene region and insulin-dependent diabetes mellitus (IDDM).Am J Hum Genet 1993;52:506-516.
37 Van Steen K,McQueen MB,Herbert A,Raby B,Lyon H,Demeo DL,Murphy A,Su J,Datta S,Rosenow C,Christman M,Silverman EK,Laird NM,Weiss ST,Lange C.Genomic screening and replication using the same data set in family-based association testing.Nat Genet 2005;37:683-691.
38 孟海娇,洪震,朱国行.CABRG2基因多态性在GEFS+中分布的研究.神经疾病与精神卫生2003;3:411-416.
39 Chou IC,Peng C,Huang CC,et al.Association analysis of gamma 2 subunit of gamma amino butyric acid type A receptor polymorphisms with febrile seizures Pediat Res 2003;54:26-29.
40 Kananura C,Haug K,Sander T,et al.A splice-site mutation in GABRG2 associated with childhood absence epilepsy and febrile convulsions.Arch Neurol 2002;59:1137-1141.
41 Kinirons P,Cavalleri GL,Shahwan A.Examining the role of common genetic variation in the γ2 subunit of the GABAA receptor in epilepsy using tagging SNPs.Epilepsy Res 2006;70:229-38.
42 Xiumin Wang,Meichun Xu,Lizhong Du/Association Analysis of γ2 Subunit of γ-aminobutyric Acid(GABA) Type A Receptor and Voltage-gated Sodium Channel Type Ⅱα-polypeptide Gene Mutation in Southern Chinese Children With Febrile Seizures.J Child Neurol 2007;22:714-9.
43 Nabbout R,Baulac S,Desguerre I,et al.New locus for febrile seizures with absence epilepsy on 3p and a possible modifier gene on 18p.Neurology 2007;68;1374-1381.
44 Fendri-Kria N,Kammoun K,Rebai A.Genetic screening of two Tunisian families with generalized epilepsy with febrile seizures plus.European Journal of Neurology 2009 Feb 19.[Epub ahead of print]
45 Kang HJ,Choi KO,Kim BD.FESD:a Functional Element SNPs Database in human.Nucleic Acids Research 2005;33:518-522.
46 Lossin C.A catalog of SCN1A variants.Brain & Development 2009;31:114-130.
47 Bonanni P,Malcame M,Moro F,et al.Generalized epilepsy with febrile seizures plus (GEFS+):clinical spectrum in seven Italian families unrelated to SCNIA,SCN1B,and GABRG2 gene mutations.Epilepsia 2004;45:149-158.
48 Wallace RH,Wang DW,Sing R,et al.Febrile seizures and generalized epilepsy associated with a mutation in the Nal-channel bl subunit gene SCN1B.Nat Genet 1998;19:366-370.
49 Wallace R,Scheffer IE,Parasivam G,et al.Generalised epilepsy with febrile seizures plus:mutation of the sodium channel subunit SCN1B.Neurology 2002;58:1426-9.
50 Audenaert D,Claes L,Ceulemans B,et al.A deletion in SCN1B is associated with febrile seizures and early-onset absence epilepsy.Neurology 2003;61:854-6.
51 Scheffer IE,Harkin LA,Grinton BE,et al.Temporal lobe epilepsy and GEFS+phenotypes associated with SCN1B mutations.Brain 2007;130:100-109.
52 Escayg A,MacDonald BT,Meisler MH,et al.Mutations of SCNIA,encoding a neuronal sodium channel,in two families with GEFS+2.Nat Genet 2000;24:343-5.
53 Escayg A,Heils A,MacDonald BT,et al.A novel SCNIA mutation associated with generalized epilepsy with febrile seizures plus and prevalence of variants in patients with epilepsy.Am J Hum Genet 2001;68:866-73.
54 Wallace RH,Scheffer IE,Barnett S,et al.Neuronal sodium-channel alpha 1-subunit mutations in generalized epilepsy with febrile seizures plus.Am J Hum Genet 2001;68:859-65.
55 Abou-Khalil B,Ge Q,Desai R,et al.Partial and generalized epilepsy with febrile seizures plus and a novel SCNIA mutation.Neurology 2001;57:2265-72.
56 Annesi G,Gambardella A,Carrideo S,et al.Two novel SCNIA missense mutations in generalized epilepsy with febrile seizures plus.Epilepsia 2003;44:1257-8.
57 Lossin C,Rhodes TH,Desai RR,et al.Epilepsy-associated dysfunction in the voltage-gated neuronal sodium channel SCNIA.J Neurosci 2003;23:11289-95.
58 Spampanato J,Kearney J A,de Haan G,et al.A novel epilepsy mutation in the sodium channel SCNIA identifies a cytoplasmic domain for beta subunit interaction.J Neurosci 2004;24:10022-34.
59 Pineda-Trujillo N,Carrizosa J,Cornejo W,et al.A novel SCNIA mutation associated with severe GEFS+in a large South American pedigree.Seizure 2005;14:123-8.
60 Barela AJ,Waddy SP,Lickfett JG,et al.An epilepsy mutation in the sodium channel SCNIA that decreases channel excitability.J Neurosci 2006;26:2714-23.
61 Selmer KK,Egeland T,Solaas MH et al.Genetic screening of Scandinavian families with febrile seizures and epilepsy or GEFS+.Acta Neurol Scand 2008;117:289-92.
62 Marini C,Mei D,Temudo T,Ferrari AR,Buti D,Dravet C,et al.Idiopathic epilepsies with seizures precipitated by fever and SCN1A abnormalities.Epilepsia 2007;48:1678-85.
63 ZuccaC,Redaelli F,EpifanioR,et al.Cryptogenic Epileptic Syndromes Related to SCN1A.Arch Neuro.2008;65(4):489-494.
64 Mantegazza M,Gambardella A,Rusconi R,et al.Identification of an Nav1.1 sodium channel(SCN1A) loss-offunction mutation associated with familial simple febrile seizures.Proc Natl Acad Sci 2005;102:18177-18182.
65 Marini C,Mei D,Cross H,Guerrini R.Mosaic SCN1A mutation in familial severe myoclonic epilepsy of infancy.Epilepsia 2006;47:1737-40.
66 Kimura K,Sugawara T,Mazaki-Miyazaki E,Hoshino K,Nomura Y,Tateno A,et al.A missense mutation in SCN1A in brothers with severe myoclonic epilepsy in infancy(SMEI) inherited from a father with febrile seizures.Brain Dev 2005;27:424-30.
67 Gennaro E,Santorelli FM,Bertini E,Buti D,Gaggero R,Gobbi G,et al.Somatic and germline mosaicisms in severe myoclonic epilepsy of infancy.Biochem Biophys Res Commun 2006;341:489-93.
68 Annesi G,Gambardella A,Carrideo S,Incorpora G,Labate A,Pasqua AA,et al.Two novel SCN1A missense mutations in generalized epilepsy with febrile seizures plus.Epilepsia 2003;44:1257-8.
69 Dlugos D J,Ferraro TN,Buono RJ.Novel De Novo Mutation of a Conserved SCN1A Amino-Acid Residue(R1596).Pediatr Neurol 2007;37:303-305.
70 Nagao Y,Mazaki-Miyazaki E,Okamura N,Takagi M,Igarashi T,Yamakawa K.A family of generalized epilepsy with febrile seizures plus type 2-a new missense mutation of SCN1A found in the pedigree of several patients with complex febrile seizures.Epilepsy Res 2005;63:151-6.
71 Hindocha N,NashefL,ElmslieF.Two cases of sudden unexpected death in epilepsy in a GEFS+ family with an SCN1A mutation.Epilepsia 2008;49:360-365.
72 Sugawara T,Mazaki-Miyazaki E,Ito M,et al.Nav1.1 mutations cause febrile seizures associated with afebrile partial seizures.Neurology 2001;57:703-5.
73 Liao WP,Shi YW,Qin B.Partial epilepsy with febrile seizure plus:A subtype of GEFS+ or SME? Neurology Asia 2007;12(Supplement 1):78-79.
74 陈俐,石奕武,邓维意.部分性痫伴热性惊厥附加症家系中的SCNlA基因嵌合突变.中华神经科杂志2008;41:580-584.
75 Kumakura A,Ito M,Hata D,et al.Novel de novo splice-site mutation of SCN1A in a patient with partial epilepsy with febrile seizures plus.Brain Dev 2009;31:179-82.
76 Wallace RH,Marini C,Petrou S,et al.Mutant GABAA receptor gamma2 subunk in childhood absence epilepsy and febrile seizures.Nat Genet,2001;28(1):49-52.
77 Audenaert D,Claes L,Claeys KG,et al.A novel susceptibility locus at 2p24 for generalized epilepsy with febrile seizures plus.J Med Genet.2005;42(12):947-952.
78 Ito M,Yamakawa K,Sugawara T.Phenotypes and genotypes in epilepsy with febrile seizures plus.Epilepsy Research 2006;70:199-205.
79 Dai X,Chen W,Wang X,et al.A novel genetic locus for familial febrile seizures and epilepsy on chromosome 3q26.2-q26.33.Hum Genet 2008;124:423-429.
80 Nabbout R,Prud'homme JF,Herman A,et al.A locus for simple pure febrile seizures maps to chromosome 6q22-q24.Brain 2002;125:2668-2680.
81 Hedera P,Ma S,Blair MA,et al.Identification of a novel locus for febrile seizures and epilepsy on chromosome 21q22.Epilepsia 2006;47:1622-1628.
82 Baulac S,Picard F,Herman A,et al.Evidence for digenic inheritance in a family with both febrile convulsions and temporal lobe epilepsy implicating chromosomes 18qter and lq25-q31.Ann Neurol 2001;49:786-792.
83 Claes L,Audenaert D,Deprez L,et al.Novel locus on chromosome 12q22-q23.3 responsible for familial temporal lobe epilepsy associated with febrile seizures.J Med Genet 2004;41:710-4.
84 Lerche H,Weber Y G,Baier H,et al.Generalized epilepsy with febrile seizures plus Further heterogeneity in a large family.Neurology 2001;57:1191-1198.
85 Ge'rard F,Pereira S,Robaglia-Schlupp A.Clinical and Genetic Analysis of a New Mukigenerational Pedigree with GEFS+ (Generalized Epilepsy with Febrile Seizures Plus).Epilepsia,2002;43(6):581-586.
86 Ristic AJ,Jankovic S,Annesi G.Generalized epilepsy with febrile seizures plus:clinical and genetic analysis of three Serbian families.Srp Arh Celok Lek 2005;133:7-13.
87 Mrabet H,Belhedi N,Bouchlaka S.GEFS+ is not related to the most common mutations of SCN1B,SCN1A and GABRG2 in two Tunisian families.Neurol Sci 2007;28:311-314.
88 Audenaert D,Claes L,Claeys KG,et al.A novel susceptibility locus at 2p24 for generalized epilepsy with febrile seizures plus.J Med Genet.2005;42(12):947-952.
89 Baulac S,Gourfinkel-An I,Couarch P,et al.A Novel Locus for Generalized Epilepsy With Febrile Seizures Plus in French Families.Arch Neurol 2008;65:943-951.
90 Malacarne M,Madia F,Gennaro E.Lack of SCN1A Mutations in Familial Febrile Seizures.Epilepsia 2002;43:559-562.
91 Dibbens LM,Feng HJ,Richards MC,et al.GABRD encoding a protein for extra or perisynaptic GABAA receptors is a susceptibility locus for generalised epilepsies.Hum Mol Genet 2004;13:1315-1319.
92 Ma S,Abou-Khalil B,Blair MA,et al.Mutations in GABRA1,GABRA5,GABRG2 and GABRD receptor genes are not a major factor in the pathogenesis of familial focal epilepsy preceded by febrile seizures.Neuroscience Letters 2006;394:74-78.
93 Nakayama J.Progress in searching for the febrile seizure susceptibility genes.Brain & Development 2009 Feb 6.[Epub ahead of print].
94 Audenaert D,Broeckhoven CV,Jonghe PD.Genes and Loci Involved in Febrile Seizures and Related Epilepsy Syndromes.Human Mutation 2006;27,391-401.
95 Baulac S,Gourfinkel-An I,Nabbout R,et al.Fever,genes,and epilepsy.Lancet Neurol 2004;3:421-30.
96 Morimoto M,Mazaki E,Nishimura A,Chiyonobu T,Sawai Y,Murakami A,et al.SCN1A mutation mosaicism in a family with severe myoclonic epilepsy in infancy.Epilepsia 2006;47:1732-6.
97 Depienne C,Arzimanoglou A,Trouillard O,Fedirko E,Baulac S,Saint-Martin C,et al.Parental mosaicism can cause recurrent transmission of SCN1A mutations associated with severe myoclonic epilepsy of infancy.Hum Mutat 2006;27:389.
98 Nabbout A,Kozlovski A,Gennaro E.Absence of mutations in major GEFS+ genes in myoclonic astatic epilepsy.Epilepsy Research 2003;56:127-133.
99 Ohmori I,Ouchida M,Ohtsuka Y,et al..Significant correlation of the SCN1A mutations and severe myoclonic epilepsy in infancy.B.B.R.C.2002;295:17-23.
100 Harkin LA,.McMahon JM,Iona X.The spectrum of SCNIA-related infantile epileptic encephalopathies.Brain 2007;130:843-852.
101 Depondt C,Van Paesschen W,Matthijs G,Legius E,Martens K,Demaerel P,Wilms G.Familial temporal lobe epilepsy with febrile seizures.Neurology 2002;58:1429-33.
102 Berkovic SF,Mcintosh A,Howell RA,et al.Familial temporal lobe epilepsy:a common disorder identified in twins.Ann Neurol 1996;40:227-235.
103 Striano P,Gambardella A,Coppola A.Familial mesial temporal lobe epilepsy (FMTLE)A clinical and genetic study of 15 Italian families.J neurol 2008 Jan;255:16-23
104 Kanai K,Hirose S,Oguni H.Effect of localization of missense mutations in SCN1A on epilepsy phenotype severity.Neurology 2004;63:329-334.
105 Deng YH,Berkovic SF,Scheffer IE.GEFS+ where focal seizures evolve from generalized spike wave:video-EEG study of two children.Epileptic Disord 2007;9:307-14.
106 Ito M,Ohmori I,Nakahori T,et al.Mutation screen of GABRAl,GABRB2 and GABRG2 genes in Japanese patients with absence seizures
107 Sigel E,Buhr A.The benzodiazepine binding site of GABA,receptors.TiPS 1997;18:425-429.
108 Schweizer C,Balsiger S,Bluethmann H.The V 2 subunit of GABAA receptors is required for maintenance of receptors at mature synapses.Molecular and Cellular Neuroscience 2003;24:442-450.
109 Berezhnoy D,Nyfeler Y,Gonthier A.On the benzodiazepine binding pocket in GABA_A receptors.J bio chem 2004;279:3160-3168.
1.中华医学会.临床诊疗指南癫痫病分册.北京:人民卫生出版社,2007,118.
2.Fisher RS,van Erode Boas W,Blume W,et al.Epileptic seizures and epilepsy.Definitions proposed by the International League against Epilepsy(ILAE) and the International Bureau for Epilepsy(IBE).Epilepsia 2005;46:470-2.
3.Leone M,Beghi E.Epilepsy and quality of life inadults:A review of instruments.Epilepsia 2005;66:23-44.
4.Baker C.Assessment of Quality of Life in people with epilepsy:Some practical implications.Epilepsia 2001;42(Suppl.3):66-69.
5.Cowan J,Baker C.A review of subjective impact measures for use with children and adolescents with epilepsy.Quality of Life Research 2004;13:1435-1443.
6.Ronen GM,Streiner DL,Rosenbaum P.Health-related quality of life in children with epilepsy:Development and validation of self-report and parent proxy measures.Epilepsia 2003;44(4):598-612.
7.Sabaz M,et al.Validation of a new quality of life measure for children with epilepsy.Epilepsia 2000;41(6):765-774.
8.Cramer JA,Westbrook L,Devinsky O,Perrine K,Glassman M,Camfield C.Development of the quality of life in epilepsy inventory for adolescents:the QOLIE-AD-48.Epilepsia 1999;40:1114-21.
9.Benavente-Aguilar A,Morales C,Rubio E.Adaptacion transcultural delcuestionario de medida de calidad de vida (QOLIE-AD-48)en adolescentes epilepticos.Psiquis 2002;23:226-37.
10.Stevanovic D,Lozanovic-Miladinovic D,Jovic N,Sarenac M.The Serbian QOLIEAD-48:translation,cultural adaptation,and preliminary psychometric evaluation.Epilepsy Behav 2005;7:240-5.
11.Barbosa FD,Guerreiro MM,Pedroso de Souza EA.The Brazilian version of the Quality of Life in Epilepsy Inventory for Adolescents:Translation,validity,and reliability.Epilepsy Behav 2008;13:218-22.
12.Devinsky O,Westbrook L,Cramer J,Glassman M,Perrine K,Camfield C.Risk Factors for Poor Health-Related Quality of Life in Adolescents with Epilepsy.Epilepsia 1999;40:1715-20.
13.Benavente-Aguilar I,Morales-Blanquez C,Rubio EA,Rey JM.Quality of life of adolescents suffering from epilepsy living in the community.J Paediatr Child Health.2004;40:110-3.
14.Ficker DM,Privitera M,Krauss G,Kanner A,Moore JL,Glauser T.Improved tolerability and efficacy in epilepsy patients with extended-release carbamazepine.Neurology 2005;65:593-5.
15.Stevanovic D.Health-related quality of life in adolescents with well-controlled epilepsy.Epilepsy Behav 2007;10:571-5.
16.Jakovljevic MB,Jankovic SM,Jankovic SV,Todorovic N.Inverse correlation of valproic acid serum concentrations and quality of life in adolescents with epilepsy.Epilepsy Res 2008;80:180-3.
17.Chassany O,Sagnier P,Marquis P,Fullerton S,Aaronson N.Patient-reported outcomes:the example of health-related quality of life—a European guideline document for the improved integration of health-related quality of life assessment in the drug regulatory process.Drug Inf J 2002;36:209-38.
18.Bonett,Douglas..Sample Size Requirements for Testing and Estimating Coefficient Alpha.Journal of Educational and Behavioral Statistics 2002;27:335-340.
19.Walter SD,Eliasziw M,Dormer A.Sample size and optimal designs for reliability studies.Statistics in Medicine 1998;17:101-110.
20.Osborne,Jason & Anna B.Costello.Best practices in exploratory factor analysis:four recommendations for getting the most from your analysis.Practical Assessment Research & Evaluation 2005;10(7).Available online:http://pareonline.net/getvn.asp?v=10&n=7.
21.Kazis LE,Anderson JJ,Meenan RF.Effect sizes for interpreting changes in health status.Med Care.1989;27(Suppl.3):S178-S189.
22.Cull A,Sprangers M,Bjordal K,on behalf of the EORTC Quality of Life Group.EORTC Quality of Life Group translation procedure.Brussels:EORTC Publications,2002.
23.Varni JW,Seid M,Kurtin PS.PedsQLTM 4.0:reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations.Medical Care,2001;39:800-812.
24.Varni JW,Seid M,Knight TS,Uzark K,Szer IS.The PedsQLTM4.0 Generic Core Scales:sensitivity,responsiveness,and impact on clinical decision-making.Journal of Behavioral Medicine 2002;25:175-193.
25.Varni JW,Burwinkle TM,Seid M,Skarr D.The PedsQLTM 4.0 as a pediatric population health measure:feasibility,reliability,and validity.Ambulatory Pediatrics 2003;3:329-341.
26.Varni JW,Seid M,Kurtin PS.PedsQL~(TM)4.0:reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations.Medical Care,2001;39:800-812.
27.Chan KS,Mangione-Smith R,Burwinkl TM,Rosen M,Varni JW.The PedsQL~(?):reliability and validity of the short-form generic core scales and Asthma Module.Medical Care 2005;43,256-265.
28.Varni JW,Seid M,Kurtin PS.PedsQL~(?)4.0:reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations.Medical Care,2001;39:800-812.
29.Acquadro C,Conway K,Hareendran A,Aaronson N;European Regulatory Issues and Quality of Life Assessment (ERIQA)Group.Literature Review of Methods to Translate Health-Related Quality of Life Questionnaires for Use in Multinational Clinical Trials.Value Health.2008;11:509-21.
30.Andresen EM.Criteria for Assessing the Tools of Disability Outcomes Research.Arch Phys Med Rehabil 2000;81(Suppl 2):15-20.
31.Yam WK,Ronen GM,Cherk SW,et aL Health-related quality of life of children with epilepsy in Hong Kong:How does it compare with that of youth with epilepsy in Canada? Epilepsy Behav 2008;12:419-426.
32.Yam WK,Ma DK,Cherk SW;Working Group for Multi-Centre Study on Quality of Life Measures for Youth with Epilepsy.Factor structure and construct validity of the Chinese health-related quality of life measure for youth with epilepsy.Epilepsy Behav 2006;9:606-618.
33.Fong CY,Hung A.Public awareness,attitude,and understanding of epilepsy in Hong Kong Special Administrative Region,China.Epilepsia 2002;43:311-6.
34.Lai CW,Huang XS,Lai YH,Zhang ZQ,Liu GJ,Yang MZ.Survey of public awareness,understanding,and attitudes toward epilepsy in Henan province,China.Epilepsia 1990;31:182-7.
35.Chung MY,Chang YC,Lai YH,Lai CW.Survey of public awareness,understanding,and attitudes toward epilepsy in Taiwan.Epilepsia 1995;36:488-93.
36.Jacoby A,Snape D,Baker GA.Epilepsy and social identity:the stigma of a chronic neurological disorder.Lancet Neurol 2005;4:171-8.
37.Kwan P,Sander JW.History of Epilepsy in Chinese Traditional Medicine.J Neurol Neurosurg Psychiatry 2004;75(10):1376-81.
38.MacLeod JS,Austin JK.Stigma in the lives of adolescents with epilepsy:a review of the literature.Epilepsy Behav 2003;4:112-7.
39.Cowan J,Baker GA.A review of subjective impact measures for use with children and adolescents with epilepsy.Qual Life Res 2004;13:1435-43.
40.Terwee CB,Dekker FW,Wiersinga WM,et al.On assessing responsiveness of health-related quality of life instruments:Guidelines for instrument evaluation.Quality of Life Research 2003;12:349-362.
41.Wang M,Wu La,Zheng Y,et al.The Chinese QOLIE-AD-48:Translation,validity,and reliability.Epilepsy Behav 2009;14:476-80. Engel Jr.J.Report of the ILAE Classification Core Group.Epilepsia,2006;47:1558-t58.
2 Scheffer I,Berkovic S.Generalized(genetic) epilepsy with febrile seizures plus.In:Engel JJ,Pedley T,editors.Epilepsy:a comprehensive textbook.Philadelphia:Lippincott,Williams & Wilkins;2008.p.2553-8.
3 Ingrid E.Scheffer,Yue-Hua Zhang,Floor E.Jansen,et al.Dravet syndrome or genetic (generalized)epilepsy with febrile seizures plus? Brain & Development.Onlie.
4 Dube CM,Brewster AL,Richichi C,et al.Fever,febrile seizures and epilepsy.Trends Neurosci 2007;30:490-496.
5 Baulac S,Gourfinkel-An I,Nabbout R,et al.Fever,genes,and epilepsy.Lancet Neurol 2004;3:421-30.
6 Sadleir LG,Scheffer IE.Febrile seizures.BMJ 2007;334;307-311.
7 Fetveit A.Assessment of febrile seizures in children.Eur J Pediatr 2008;1671:17-27.
8 Wallace RH,Berkovic SF,Howell RA,et al.Suggestion of a major gene for familial febrile convulsions mapping to 8q13-21.J Med Genet 1996;33:308-312.
9 Johnson EW,Dubovsky J,Rich SS,et al.Evidence for a novel gene for familial febrile convulsions,FEB2,linked to chromosome 19p in an extended family from the Midwest.Hum Mol Genet 1998;7:63-67.
10 Peiffer A,Thompson J,Charlier C,et al.A locus for febrile seizures (FEB3)maps to chromosome 2q23±24.Ann Neurol 1999;46:671-8.
11 Mantegazza M,Gambardella A,Rusconi R,et al.Identification of an Nav1.1 sodium channel (SCN1A)loss-offunction mutation associated with familial simple febrile seizures.Proc Natl Acad Sci 2005;102:18177-18182.
12 Colosimo E,Gambardella A,Mantegazza M,et al.Electroclinical Features of a Family with Simple Febrile Seizures and Temporal Lobe Epilepsy Associated with SCN1A Loss-of-function Mutation.Epilepsia 2007;48:1691-1696.
13 Nakayama J,Hamano K,Iwasaki N,et al.Significant evidence for linkage of febrile seizures to chromosome 5q14-q15.Hum Mol Genet 2000;9:87-91.
14 Nakayama J,Fu YH,Clark AM,et al.A nonsense mutation of the MASS1 gene in a family with febrile and afebrile seizures.Ann Neurol 2002;52:654-657
15 Deprez L,Claes LR,Claeys KG,et al.Genome-wide linkage of febrile seizures and epilepsy to the FEB4 locus at 5q14.3-q23.1 and no MASS1 mutation.Hum Genet 2006;118:618-625.
16 Nabbout R,Prud'homme JF,Herman A,et al.A locus for simple pure febrile seizures maps to chromosome 6q22-q24.Brain 2002;125:2668-2680.
17 Nakayama J,Yamamoto N,Hamano K,et al.Linkage and association of febrile seizures to the IMPA2 gene on human chromosome 18.Neurology 2004;63:1803-1807.
18 Hedera P,Ma S,Blair MA,et al.Identification of a novel locus for febrile seizures and epilepsy on chromosome 21q22.Epilepsia 2006;47:1622-1628.
19 Audenaert,D,Schwartz E,Claeys KG,et al.(2006)A novel GABRG2 mutation associated with febrile seizures.Neurology 67,687-690.
20 Nabbout R,Baulac S,Desguerre I,et al.New locus for febrile seizures with absence epilepsy on 3p and a possible modifier gene on 18p.Neurology 2007;68;1374-1381.
21 Dai X,Chen W,Wang X,et al.A novel genetic locus for familial febrile seizures and epilepsy on chromosome 3q26.2-q26.33.Hum Genet 2008;124:423-429.
22 Hindocha N,NabboutR,Elmslie F.A case report of a family with overlapping features of autosomal dominant febrile seizures and GEFS+.Epilepsia Online.
23 SchefferIE,Berkovic SF.Generalised epilepsy with febrile seizures plus-a genetic disorder with heterogeneous clinical phenotypes.Brain 1997;120,479-490.
24 Singh R,Scheffer IE,Crossland K,et al.Generalized epilepsy with febrile seizures plus (GEFS1):a common,childhood-onset,genetic epilepsy syndrome.Ann Neuro 1999;145:75-81.
25 Engel J Jr.A proposed diagnostic scheme for people with epileptic seizures and with epilepsy:Report of the ILAE task force on classification and terminology.Epilepsia,2001,42:796-803.
26 Wallace RH,Wang DW,Sing R,et al.Febrile seizures and generalized epilepsy associated with a mutation in the Nal-channel b1 subunit gene SCN1B.Nat Genet 1998;19:366-370.
27 Meadows LS,Malhotra J,LoukasA,et al.Functional and Biochemical Analysis of a Sodium Channel _1 Subunit Mutation Responsible for Generalized Epilepsy with Febrile Seizures Plus Type 1.J Neurosci 2002;22:10699-10709.
28 Audenaert D,Claes L,Ceulemans B,et al.A deletion in SCN1B is associated with febrile seizures and early-onset absence epilepsy.Neurology 2003;61:854-6.
29 Wallace R,Scheffer IE,Parasivam G,et al.Generalised epilepsy with febrile seizures plus:mutation of the sodium channel subunit SCN1B.Neurology 2002;58:1426-9.
30 Scheffer IE,Harkin LA,Grinton BE,et al.Temporal lobe epilepsy and GEFS+ phenotypes associated with SCN1B mutations.Brain 2007;130:100-109.
31 Lossin C.A catalog of SCN1A variants.Brain Dev 2009;312:114-30.
32 Baulac S,Gourfinkel-An I,Picard F,et al.A second locus for familial generalized epilepsy with febrile seizures plus maps to chromosome 2q21-q33.Am J Hum Genet 1999;65:1078-85.
33 Moulard B,Guipponi M,Chaigne D,et al.Identification of a new locus for generalized epilepsy with febrile seizures plus (GEFS+)on chromosome 2q24-q33.Am J Hum Genet 1999;65:1396-400.
34 Lopes-Cendes I,Scheffer I E,Berkovic SF,et al.A New Locus for Generalized Epilepsy with Febrile Seizures Plus Maps to Chromosome 2.Am J Hum Genet 2000;6(5:698-701.
35 Escayg A,MacDonald BT,Meisler MH,et al.Mutations of SCNIA,encoding a neuronal sodium channel,in two families with GEFS+2.Nat Genet 2000;24:343-5.
36 Escayg A,Heils A,MacDonald BT,et al.A novel SCNIA mutation associated with generalized epilepsy with febrile seizures plus and prevalence of variants in patients with epilepsy.Am J Hum Genet 2001;68:866-73.
37 Wallace RH,Scheffer IE,Barnett S,et al.Neuronal sodium-channel alpha 1-subunit mutations in generalized epilepsy with febrile seizures plus.Am J Hum Genet 2001;68:859-65.
38 Abou-Khalil B,Ge Q,Desai R,et al.Partial and generalized epilepsy with febrile seizures plus and a novel SCNIA mutation.Neurology 2001;57:2265-72.
39 Annesi G,Gambardella A,Carrideo S,et al.Two novel SCNIA missense mutations in generalized epilepsy with febrile seizures plus.Epilepsia 2003;44:1257-8.
40 Lossin C,Rhodes TH,Desai RR,et al.Epilepsy-associated dysfunction in the voltage-gated neuronal sodium channel SCNIA.J Neurosci 2003;23:11289-95.
41 Spampanato J,Kearney JA,de Haan G,et al.A novel epilepsy mutation in the sodium channel SCN1A identifies a cytoplasmic domain for beta subunit interaction.J Neurosci 2004;24:10022-34.
42 Pineda-Trujillo N,Carrizosa J,Cornejo W,et al.A novel SCNIA mutation associated with severe GEFS+in a large South American pedigree.Seizure 2005;14:123-8.
43 Barela AJ,Waddy SP,Lickfett JG,et al.An epilepsy mutation in the sodium channel SCN1A that decreases channel excitability.J Neurosci 2006;26:2714-23.
44 Selmer KK,Egeland T,Solaas MH et al.Genetic screening of Scandinavian families with febrile seizures and epilepsy or GEFS+.Acta Neurol Scand 2008;117:289-92.
45 Marini C,Mei D,Temudo T,Ferrari AR,Buti D,Dravet C,et al.Idiopathic epilepsies with seizures precipitated by fever and SCNIA abnormalities.Epilepsia 2007;48:1678-85.
46 Sun H,Zhang Y,Liang J,et al.SCNIA,SCNIB,and GABRG2 gene mutation analysis in Chinese families with generalized epilepsy with febrile seizures plus.J Hum Genet 2008;53:769-74.
47 ZuccaC,Redaelli F,EpifanioR,et al.Cryptogenic Epileptic Syndromes Related to SCN1A.Arch Neuro.2008;65(4):489-494.
48 Lossin C,Wang DW,Rhodes TH,et al.Molecular basis of an inherited epilepsy.Neuron 2002;34:877-884.
49 Spampanato J,Escayg A,MeislerMH,et al.Functional effects of two voltage-gated sodium channel mutations that cause generalized epilepsy with febrile seizures plus type 2.J Neurosci 2001;21,7481-7490.
50 Spampanato J,Escayg A,Meisler MH,et al.Generalized epilepsy with febrile seizures plus type 2mutation W1204R alters voltage-dependent gating of Nav1.1 sodium channels.Neuroscience 2003;116,37-48.
51 Ragsdale DS.How do mutant Navl.l sodium channels cause epilepsy? Brain Res Rev.2008;581:149-59.
52 Lossin C,Rhodes TH,Desai RR,et al.Epilepsy-associated dysfunction in the voltage-gated neuronal sodium channel SCN1A.J Neurosci 2003;23,11289-11295.
53 Ohunori I,Ouchida M,Ohtsuka Y,et al.Significant correlation of the SCN1A mutations and severe myoclonic epilepsy in infancy.Biochem Biophys Res Commun 2002;295(1):17-23.
54 Ceulemans BP,Claes LR,Lagae LG.Clinical correlations of mutations in the SCN1A gene:from febrile seizures to severe myoclonic epilepsy in infancy.Pediatr neurol 2004;30:236-243.
55 Kanai K,Hirose S,Oguni H,et al.Effect of localization of missense mutations in SCN1A on epilepsy phenotype severity.Neurology 2004;63:329-334.
56 Baulac S,Huberfeld G,Gourfinkel AnI,et al.First Genetic evidence of GABA(A)receptor dysfunction in epilepsy:a mutation in the gamma2 subunit gene.Nat Genet2001;28:46-48.
57 Wallace RH,Marini C,Petrou S,et al.Mutant GABAA receptor gamma2 subunit in childhood absence epilepsy and febrile seizures.Nat Genet,2001;28(1):49-52.
58 Harkin LA,Bowser DN,Dibbens LM,et al.Truncation of the GABAA receptor c2-subunit in a family with generalized epilepsy with febrile seizures plus.Am J Hum Genet 2002;70:530-536.
59 Kanainura C,Haug K,Sander T,et al.A splice-site mutation in GABRG2 associated with childhood absence epilepsy and febrile convulsions.Arch Neurol 2002;59:1137-1141.
60 Sugawara T,Tsurubuchi Y,Agarwala KL,et al.A missense mutation of the Na+channel alpha II subunit gene Nav1.2 in a patient with febrile and afebrile seizures causes channel dysfunction.Proc Natl Acad Sci USA 2001;98:6384-6389.
61 Dibbens LM,Feng HJ,Richards MC,et al.GABRD encoding a protein for extra or perisynaptic GABAA receptors is a susceptibility locus for generalised epilepsies.Hum Mol Genet 2004;13:1315-1319.
62 Hua-Jun Feng,1 Jing-Qiong Kang,1 Luyan Song,δ Subunit Susceptibility Variants E177A and R220H Associated with Complex Epilepsy Alter Channel Gating and Surface Expression of α4β2δ GABAA Receptors.J Neurosci 2006;26:1499-1506.
63 Audenaert D,Claes L,Claeys KG,et al.A novel susceptibility locus at 2p24 for generalized epilepsy with febrile seizures plus.J Med Genet.2005;42(12):947-952.
64 Baulac S,Gourfinkel-An I,Couarch P,et al.A Novel Locus for Generalized Epilepsy With Febrile Seizures Plus in French Families.Arch Neurol 2008;65:943-951.
65 Sugawara T,Mazaki-Miyazaki E,Ito M,et al.Nav1.1 mutations cause febrile seizres associated with afebrile partial seizures.Neurology 2001;57:703-5.
66 Liao WP,Shi YW,Qin B.Partial epilepsy with febrile seizure plus:A subtype of GEFS+ or SME? Neurology Asia 2007;12(Supplement 1):78-79.
67 陈俐,石奕武,邓维意.部分性痫伴热性惊厥附加症家系中的SCNlA基因嵌合突变.中华神经科杂志2008;41:580-584.
68 Kumakura A,Ito M,Hata D,et al.Novel de novo splice-site mutation of SCN1A in a patient with partial epilepsy with febrile seizures plus.Brain Dev 2009;31:179-82.
69 Baulac S,Picard F,Herman A,et al.Evidence for digenic inheritance in a family with both febrile convulsions and temporal lobe epilepsy implicating chromosomes 18qter and 1q25- q31.Ann Neurol 2001;49:786-792.
70 Depondt C,Van Paesschen W,Matthijs G,Legius E,Martens K,Demaerel P,Wilms G.Familial temporal lobe epilepsy with febrile seizures.Neurology 2002;58:14129-33.
71 Claes L,Audenaert D,Deprez L,et al.Novel locus on chromosome 12q22-q23.3responsible for familial temporal lobe epilepsy associated with febrile seizures.J Med Genet 2004;41:710-4.
72 Lenzen KP,Heils A,LorenzS,et al.Association analysis of the Arg220His variation of the human gene encoding the GABAδ subunit with idiopathic generalized epilepsy.Epilepsy Res 2005;65:53-57.
73 孟海娇,洪震,朱国行.GABRG2基因多态性在GEFS+中分布的研究.神经疾病与 精神卫生 2003；3：411-416．
74 Chou IC,Peng C,Huang CC,et al.Association analysis of gamma 2 subunit of gamma amino butyric acid type A receptor polymorphisms with febrile seizures Pediat Res 2003;54:26-29.
75 Kiinirons P,Cavalleri GL,Shahwan A.Examining the role of common genetic variation in the y2 subunit of the GABAA receptor in epilepsy using tagging SNPs.Epilepsy Res 2006;70:229-38.
76 Xiumin Wang,Meichun Xu,Lizhong Du/ Association Analysis of γ2 Subunit of γ-aminobutyric Acid (GABA)Type A Receptor and Voltage-gated Sodium Channel Type Ⅱ a-polypeptide Gene Mutation in Southern Chinese Children With Febrile Seizures.J Child Neurol 2007;22:714-9.
77 Ma S,Abou-Khalil B,Sutcliffe JS,et al.The GABBR1 locus and the G1465A variant is not associated with temporal lobe epilepsy preceded by febrile seizures.BMC Med Genet 2005;6:13.
78 Chou IC,Peng CT,Tsai FJ,et al.The lack of association between febrile convulsions and polymorphisms in SCN1 A.Epilepsy Res 2003;54:53-7.
79 Nakayama K,Yamamoto N,Hamano K,et al.Failure to find evidence for association between voltage-gated sodium channel gene SCN2A variants and febrile seizures in humans.Neuroscience Letters 2002;329:249-251.
80 Haspolat S,Baysal Y,Duman O,et al.Interleukin-1α,Interleukin-1β,and Interleukin-IRa Polymorphisms in Febrile Seizures.J Child Neurol 2005;20:565-8.
81 Kanemoto K,Kawasaki J,Miyamoto T,et al.Interleukin (IL)lbeta,IL-1 alpha,and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy.Ann.Neurol 2000;47:571-574.
82 Virta M,Hurme M,Helminen M.Increased frequency of inter leukin-1 beta (-511)allele 2 in febrile seizures.Pediatr Neurol 2002;26:192-195.
83 Kira R,Torisu H,TakemotoM,et al.Genetic susceptibility to simple febrile seizures:interleukin-1beta promoter polymorphisms are associated with sporadic cases.Neurosci Lett 2005;384:239-244.
84 Tilgen N,Pfeiffer H,Cobilanschi J,et al.Association analysis between the human interleukin 1beta (-511)gene polymorphism and susceptibility to febrile convulsions.Neurosci Lett 2002;334:68-70.
85 Tsai FJ,Hsieh YY,Chang CC,et al.Polymorphisms for interleukin 1 beta exon 5 and interleukin 1 receptor antagonist in Taiwanese children with febrile convulsions.Arch.Pediatr.Adolesc Med 2002;156:545-548.
86 Nakayama J,Arinami T.Molecular genetics of febrile seizures.Epilepsy Res 2006;70:190-198.
87 Tsai FJ,Chou IC,Hsieh YY,et al.Interleukin-4 Intron 3 Polymorphism is Not Related to Suscelptibility to Febrile Seizures.Pediatr Neurol 2002;27:271-4.
88 Chou IC,Lee CC,Huang CC,et al.Association of the neuronal nicotinic acetylcholine receptor subunit alpha4 polymorphisms with febrile convulsions.Epilepsia 2003;44:1089-1093.
89 Mulley J,Heron S,Schefier I,et al.Febrile convulsions and genetic susceptibility:role of the neuronal nicotinic acetylcholine receptor aIpha 4 subunit.Epilepsia 2004;45:561.
90 马祎楠,陈志越,邹丽萍等.单纯性家族性热性惊厥与HCN2基因的相关研究.中华医学杂志2005:85:661-665.
91 Ma Y,Qi Y,Chen Z,et al.Polymorphisms of casein kinase I gamma 2 gene associated with simple febrile seizures in Chinese Han population.Neurosci Lett 2004;368:2-6.
92 Lin LC,Lin HS,Yang RC.Neuropeptide Y gene polymorphism and plasma neuropeptide Y level in febrile seizure patients in Taiwan.Kaohsiung J Med Sci 2007;23:560-5.
93 Kang HJ,Choi KO,Kim BD,et al.FESD:a Functional Element SNPs Database in human.Nucleic Acids Res 2005;33(Database issue):D518-22.
94 Dub(?) C,Richichi C,Bender RA,et al.Temporal lobe epilepsy aider experimental prolonged febrile seizures:prospective analysis.Brain 2006;129:911-22.
95 Toth Z,Yan XX,Haftoglou S,et al.Seizure-induced neuronal injury:vulnerability to febrile seizures in an immature rat model.J Neurosci 1998;18:4285-4294.
96 Jiang W,Duong TM,de Lanerolle NC,et al.The neuropathology of hyperthermic seizures in the rat.Epilepsia 1999;40:5-19.
97 Lemmens EM,Lubbers T,Schijns OE,et al.Gender differences in febrile seizure induced proliferation and survival in the rat dentate gyrus.Epilepsia 2005;46:1603-1612.
98 Chang YC,Huang AM,Kuo YM,et al.Febrile seizures impair memory and cAMP response element binding protein activation.Ann.Neuro12003;4:706-718.
99 Bender RA,Dub6 C,Gortzalez-Vega R,et al.Mossy fiber plasticity and enhanced hippocampal excitability,without hippoeampal cell loss or altered neurogenesis,in an animal model of prolonged febrile seizures.Hippocampus 2003;13:357-370.
100 Jansen JF,Lemmens EM,Strijkers G J,et al.Short- and long-term limbic abnormalities after experimental febrile seizures.Neurobiol Dis 2008;32:293-301.
101 Van Landingham KE,Heinz ER,Cavazos JE,et al.Magnetic resonance imaging evidence of hippocampal injury after prolonged focal febrile convulsions.Ann.Neurol 1998;43:413-426.
102 Scott RC,Gadian DG,King MD,et al.Magnetic resonance imaging findings within 5 days of status epilepticus in childhood.Brain 2002;125:1951-1959.
103 Scott RC,King MD,Gadian DG,et al.Hippocampal abnormalities after prolonged febrile convulsion:a longitudinal MRI study.Brain 2003;126:2551-2557.
104 Houser CR.Granule cell dispersion in the dentate gyrus of humans with temporal lobe epilepsy.Brain Res 1990;535:195-204.
105 Dube C,Yu H,Nalcioglu O,et al.Serial MRI after experimental febrile seizures:altered T2 signal without neuronal death.Ann.Neurol 2004;56:709-714.
106 Natsume J,Bernasconi N,Miyauchi M,et al.Hippocampal volumes and diffusion-weighted image findings in children with prolonged febrile seizures.Acta Neurol Scand 2007;115:25-28.
107 Tarkka R,Paakko E,Pyhtinen J,et al.Febrile seizures and mesial temporal sclerosis-No association in a long-term follow-up study.Neurology 2003;60:215-8.
108 Auer T,Barsi P,Bone B,et al.History of simple febrile seizures is associated with hippocampal abnormalities in adults.Epilepsia 2008;49:1562-9.
109 Chang YC,Huang CC,Huang SC.Long-term neuroplasticity effects of febrile seizures in the developing brain.Chang Gung Med J 2008;31:125-35.
110 Cendes F.Febrile seizures and mesial temporal sclerosis.Curr Opin Neurol.2004;17:161-4.
111 Shinnar S.Febrile seizures and mesial temporal sclerosis.Epilepsy Curr 2003;3:115-118.
2 Ingrid E.Scheffer,Yue-Hua Zhang,Floor E.Jansen,et al.Dravet syndrome or genetic(generalized) epilepsy with febrile seizures plus? Brain & Development.2009 Feb 7.[Epub ahead of print]
3 Scheffer IE,Berkovic SF.Generalised epilepsy with febrile seizures plus-a genetic disorder with heterogeneous clinical phenotypes.Brain 1997;120,479-490.
4 Engel Jr.J.Report of the ILAE Classification Core Group.Epilepsia,2006;47:1558-68.
5 席妹景,黄希顺,魏建科等.全面性癫痫伴热性惊厥附加症6家系SCNlB基因突变筛查.[J]实用儿科临床杂志,2007,22:436-440.
6 常秀红,黄希顺,魏建等.GABRG2在全面性癫痫伴热性惊厥附加症中的研究.[J]神经疾病与精神卫生,2007,7:89-93.
7 周水珍,宋义清,陈超等.全面性癫痫伴热性惊厥附加症的临床与分子遗传学研究.[J]中华神经科杂志2007,40:465-470.
8 张守山,黄希顺,王家勤等.全面性癫痫伴热性惊厥附加症家系GABRB2基因测序研究.[J]实用儿科临床杂志,2006,21:30-31.
9 林华,王玉平,王梦阳等.全面性癫痫伴热性惊厥附加症家系致病基因的连锁定位和突变分析.[J]中华医学杂志,2008,88:3177-3188.
10 魏建科,黄希顺,尹景岗.全身性癫痫伴热性惊厥附加症家系GABRA1基因测序分析.[J]中国现代医学杂志,2006,16:21-25.
11 魏建科,魏华,黄希顺.全身性癫痫伴热性惊厥附加症2个家系致病基因GABRG2测序分析.[J]郑州大学学报,2006,41:1049-1052.
12 LIU X,DENG Y,LIAO P,et al.The clinical and genetic features of generalized epilepsy with febrile seizure plus(GEFS+) in Chinese families.Neurology Asia 2004;9(Supplement 1):91.
13 Sun H,Zhang Y,Liang J,et al.SCNIA,SCN1B,and GABRG2 gene mutation analysis in Chinese families with generalized epilepsy with febrile seizures plus.J Hum Genet 2008;53:769-74.
14 Hindocha N,Nabbout R,Elmslie F,et al.A case report of a family with overlapping features of autosomal dominant febrile seizures and GEFS+.Epilepsia 2008 Nov 19.[Epub ahead of print].
15 Liao WP,Shi YW,Qin B.Partial epilepsy with febrile seizure plus:A subtype of GEFS+ or SME? Neurology Asia 2007;12(Supplement 1):78-79.
16 陈俐,石奕武,邓维意.部分性痫伴热性惊厥附加症家系中的SCNlA基因嵌合突变.中华神经科杂志2008;41:580-584.
17 Baulac S,Huberfeld G,Gourfinkel Anl,et al.First Genetic evidence of GABA(A)receptor dysfunction in epilepsy:a mutation in the gamma2 subunit gene.Nat Genet2001;28:46-48.
18 Harkin LA,Bowser DN,Dibbens LM,et al.Truncation of the GABAA receptor c2-subunit in a family with generalized epilepsy with febrile seizures plus.Am J Hum Genet 2002;70:530-536.
19 Deng H,Xie Wa,Le W,et al.Genetic analysis of the GABRA1 gene in patients with essential tremor.Neuroscience Letters 2006;401:16-19.
20 王铮.单基因遗传病的突变筛查与分子遗传学分析[D].北京:北京协和医学院中国医学科学院,2008:22-24.
21 Lathrop GM,Lalouel JM Easy calculations of LOD scores and genetic risks on small computers.Am J Hum Genet 1984;36:460-465.
22 LeeY,LeeY,Kim B.ECgene:an alternative splicing database update.Nucleic Acids Research 2007,35:99-103.
23 Bhatti P,Church DM,Rutter JL.Candidate Single Nucleotide Polymorphism Selection using Publicly Available Tools:A Guide for Epidemiologists Am J Epidemiol 2006;164:794-804.
24 Kast C,WangM,Whiteway M.The ERK/MAPK Pathway Regulates the Activity of the Human Tissue Factor Pathway Inhibitor-2 Promoter.J Biol Chem 2003;278:6787-6794.
25 林华.全面性癫痫伴热性惊厥附加症家系致病基因定位及克隆研究[D].北京:北京协和医学院 中国医学科学院,2007:37-47.
26 Singh R,Scheffer IE,Crossland K,et al.Generalized epilepsy with febrile seizures plus:a common childhood-onset genetic epilepsy syndrome.Ann Neurol 1999;45:75-81.
27 Lerche H,Weber YG,Bater H,et al.Generalized epilepsy with febrile seizures plus:further heterogeneity in a large family.Neurology 2001;57:1191-1198.
28 人类分子遗传学
29 马厚勋,牛永红,李章勇等.等位基因特异性引物PCR技术及其应用研究.生物技术,2005,15:15-18.
30 周晨慧,彭惠民.双向等位特异PCR技术及其在单核苷酸多态性研究中的应用.重庆医科大学学报2006,31:658-661.
31 Wingender,E.,Dietze,P.,Karas,H.and Knu(?)ppel,R.(1996) TRANSFAC:a database on transcription factors and their DNA binding sites.Nucleic Acids Res 24;238-241.
32 Chekmenev DS,Haid C,.Kel A E.P-Match:transcription factor binding site search by combining patterns and weight matrices.Nucleic Acids Research 2005;33,Web Server issue.
33 Ponomarenko JV,Merkulova TI,Orlova GV.rSNP_Guide,a database system for analysis of transcription factor binding to DNA with variations:application to genome annotation.Nucleic Acids Research 2003;31:118-121.
34 CossettelP,Liu L,Briseboisl K,et al.Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy.nature genetics 2002;31:184-9.
35 A Mutation in the GABAA Receptor _1-Subunit Is Associated with Absence Epilepsy Maljevic S,Krampfl K,Cobilanschi J.Ann Neurol 2006;59:983-987.
36 Spielman RS,McGinnis RE,Ewens WJ.Transmission test for linkage disequilibrium:the insulin gene region and insulin-dependent diabetes mellitus (IDDM).Am J Hum Genet 1993;52:506-516.
37 Van Steen K,McQueen MB,Herbert A,Raby B,Lyon H,Demeo DL,Murphy A,Su J,Datta S,Rosenow C,Christman M,Silverman EK,Laird NM,Weiss ST,Lange C.Genomic screening and replication using the same data set in family-based association testing.Nat Genet 2005;37:683-691.
38 孟海娇,洪震,朱国行.CABRG2基因多态性在GEFS+中分布的研究.神经疾病与精神卫生2003;3:411-416.
39 Chou IC,Peng C,Huang CC,et al.Association analysis of gamma 2 subunit of gamma amino butyric acid type A receptor polymorphisms with febrile seizures Pediat Res 2003;54:26-29.
40 Kananura C,Haug K,Sander T,et al.A splice-site mutation in GABRG2 associated with childhood absence epilepsy and febrile convulsions.Arch Neurol 2002;59:1137-1141.
41 Kinirons P,Cavalleri GL,Shahwan A.Examining the role of common genetic variation in the γ2 subunit of the GABAA receptor in epilepsy using tagging SNPs.Epilepsy Res 2006;70:229-38.
42 Xiumin Wang,Meichun Xu,Lizhong Du/Association Analysis of γ2 Subunit of γ-aminobutyric Acid(GABA) Type A Receptor and Voltage-gated Sodium Channel Type Ⅱα-polypeptide Gene Mutation in Southern Chinese Children With Febrile Seizures.J Child Neurol 2007;22:714-9.
43 Nabbout R,Baulac S,Desguerre I,et al.New locus for febrile seizures with absence epilepsy on 3p and a possible modifier gene on 18p.Neurology 2007;68;1374-1381.
44 Fendri-Kria N,Kammoun K,Rebai A.Genetic screening of two Tunisian families with generalized epilepsy with febrile seizures plus.European Journal of Neurology 2009 Feb 19.[Epub ahead of print]
45 Kang HJ,Choi KO,Kim BD.FESD:a Functional Element SNPs Database in human.Nucleic Acids Research 2005;33:518-522.
46 Lossin C.A catalog of SCN1A variants.Brain & Development 2009;31:114-130.
47 Bonanni P,Malcame M,Moro F,et al.Generalized epilepsy with febrile seizures plus (GEFS+):clinical spectrum in seven Italian families unrelated to SCNIA,SCN1B,and GABRG2 gene mutations.Epilepsia 2004;45:149-158.
48 Wallace RH,Wang DW,Sing R,et al.Febrile seizures and generalized epilepsy associated with a mutation in the Nal-channel bl subunit gene SCN1B.Nat Genet 1998;19:366-370.
49 Wallace R,Scheffer IE,Parasivam G,et al.Generalised epilepsy with febrile seizures plus:mutation of the sodium channel subunit SCN1B.Neurology 2002;58:1426-9.
50 Audenaert D,Claes L,Ceulemans B,et al.A deletion in SCN1B is associated with febrile seizures and early-onset absence epilepsy.Neurology 2003;61:854-6.
51 Scheffer IE,Harkin LA,Grinton BE,et al.Temporal lobe epilepsy and GEFS+phenotypes associated with SCN1B mutations.Brain 2007;130:100-109.
52 Escayg A,MacDonald BT,Meisler MH,et al.Mutations of SCNIA,encoding a neuronal sodium channel,in two families with GEFS+2.Nat Genet 2000;24:343-5.
53 Escayg A,Heils A,MacDonald BT,et al.A novel SCNIA mutation associated with generalized epilepsy with febrile seizures plus and prevalence of variants in patients with epilepsy.Am J Hum Genet 2001;68:866-73.
54 Wallace RH,Scheffer IE,Barnett S,et al.Neuronal sodium-channel alpha 1-subunit mutations in generalized epilepsy with febrile seizures plus.Am J Hum Genet 2001;68:859-65.
55 Abou-Khalil B,Ge Q,Desai R,et al.Partial and generalized epilepsy with febrile seizures plus and a novel SCNIA mutation.Neurology 2001;57:2265-72.
56 Annesi G,Gambardella A,Carrideo S,et al.Two novel SCNIA missense mutations in generalized epilepsy with febrile seizures plus.Epilepsia 2003;44:1257-8.
57 Lossin C,Rhodes TH,Desai RR,et al.Epilepsy-associated dysfunction in the voltage-gated neuronal sodium channel SCNIA.J Neurosci 2003;23:11289-95.
58 Spampanato J,Kearney J A,de Haan G,et al.A novel epilepsy mutation in the sodium channel SCNIA identifies a cytoplasmic domain for beta subunit interaction.J Neurosci 2004;24:10022-34.
59 Pineda-Trujillo N,Carrizosa J,Cornejo W,et al.A novel SCNIA mutation associated with severe GEFS+in a large South American pedigree.Seizure 2005;14:123-8.
60 Barela AJ,Waddy SP,Lickfett JG,et al.An epilepsy mutation in the sodium channel SCNIA that decreases channel excitability.J Neurosci 2006;26:2714-23.
61 Selmer KK,Egeland T,Solaas MH et al.Genetic screening of Scandinavian families with febrile seizures and epilepsy or GEFS+.Acta Neurol Scand 2008;117:289-92.
62 Marini C,Mei D,Temudo T,Ferrari AR,Buti D,Dravet C,et al.Idiopathic epilepsies with seizures precipitated by fever and SCN1A abnormalities.Epilepsia 2007;48:1678-85.
63 ZuccaC,Redaelli F,EpifanioR,et al.Cryptogenic Epileptic Syndromes Related to SCN1A.Arch Neuro.2008;65(4):489-494.
64 Mantegazza M,Gambardella A,Rusconi R,et al.Identification of an Nav1.1 sodium channel(SCN1A) loss-offunction mutation associated with familial simple febrile seizures.Proc Natl Acad Sci 2005;102:18177-18182.
65 Marini C,Mei D,Cross H,Guerrini R.Mosaic SCN1A mutation in familial severe myoclonic epilepsy of infancy.Epilepsia 2006;47:1737-40.
66 Kimura K,Sugawara T,Mazaki-Miyazaki E,Hoshino K,Nomura Y,Tateno A,et al.A missense mutation in SCN1A in brothers with severe myoclonic epilepsy in infancy(SMEI) inherited from a father with febrile seizures.Brain Dev 2005;27:424-30.
67 Gennaro E,Santorelli FM,Bertini E,Buti D,Gaggero R,Gobbi G,et al.Somatic and germline mosaicisms in severe myoclonic epilepsy of infancy.Biochem Biophys Res Commun 2006;341:489-93.
68 Annesi G,Gambardella A,Carrideo S,Incorpora G,Labate A,Pasqua AA,et al.Two novel SCN1A missense mutations in generalized epilepsy with febrile seizures plus.Epilepsia 2003;44:1257-8.
69 Dlugos D J,Ferraro TN,Buono RJ.Novel De Novo Mutation of a Conserved SCN1A Amino-Acid Residue(R1596).Pediatr Neurol 2007;37:303-305.
70 Nagao Y,Mazaki-Miyazaki E,Okamura N,Takagi M,Igarashi T,Yamakawa K.A family of generalized epilepsy with febrile seizures plus type 2-a new missense mutation of SCN1A found in the pedigree of several patients with complex febrile seizures.Epilepsy Res 2005;63:151-6.
71 Hindocha N,NashefL,ElmslieF.Two cases of sudden unexpected death in epilepsy in a GEFS+ family with an SCN1A mutation.Epilepsia 2008;49:360-365.
72 Sugawara T,Mazaki-Miyazaki E,Ito M,et al.Nav1.1 mutations cause febrile seizures associated with afebrile partial seizures.Neurology 2001;57:703-5.
73 Liao WP,Shi YW,Qin B.Partial epilepsy with febrile seizure plus:A subtype of GEFS+ or SME? Neurology Asia 2007;12(Supplement 1):78-79.
74 陈俐,石奕武,邓维意.部分性痫伴热性惊厥附加症家系中的SCNlA基因嵌合突变.中华神经科杂志2008;41:580-584.
75 Kumakura A,Ito M,Hata D,et al.Novel de novo splice-site mutation of SCN1A in a patient with partial epilepsy with febrile seizures plus.Brain Dev 2009;31:179-82.
76 Wallace RH,Marini C,Petrou S,et al.Mutant GABAA receptor gamma2 subunk in childhood absence epilepsy and febrile seizures.Nat Genet,2001;28(1):49-52.
77 Audenaert D,Claes L,Claeys KG,et al.A novel susceptibility locus at 2p24 for generalized epilepsy with febrile seizures plus.J Med Genet.2005;42(12):947-952.
78 Ito M,Yamakawa K,Sugawara T.Phenotypes and genotypes in epilepsy with febrile seizures plus.Epilepsy Research 2006;70:199-205.
79 Dai X,Chen W,Wang X,et al.A novel genetic locus for familial febrile seizures and epilepsy on chromosome 3q26.2-q26.33.Hum Genet 2008;124:423-429.
80 Nabbout R,Prud'homme JF,Herman A,et al.A locus for simple pure febrile seizures maps to chromosome 6q22-q24.Brain 2002;125:2668-2680.
81 Hedera P,Ma S,Blair MA,et al.Identification of a novel locus for febrile seizures and epilepsy on chromosome 21q22.Epilepsia 2006;47:1622-1628.
82 Baulac S,Picard F,Herman A,et al.Evidence for digenic inheritance in a family with both febrile convulsions and temporal lobe epilepsy implicating chromosomes 18qter and lq25-q31.Ann Neurol 2001;49:786-792.
83 Claes L,Audenaert D,Deprez L,et al.Novel locus on chromosome 12q22-q23.3 responsible for familial temporal lobe epilepsy associated with febrile seizures.J Med Genet 2004;41:710-4.
84 Lerche H,Weber Y G,Baier H,et al.Generalized epilepsy with febrile seizures plus Further heterogeneity in a large family.Neurology 2001;57:1191-1198.
85 Ge'rard F,Pereira S,Robaglia-Schlupp A.Clinical and Genetic Analysis of a New Mukigenerational Pedigree with GEFS+ (Generalized Epilepsy with Febrile Seizures Plus).Epilepsia,2002;43(6):581-586.
86 Ristic AJ,Jankovic S,Annesi G.Generalized epilepsy with febrile seizures plus:clinical and genetic analysis of three Serbian families.Srp Arh Celok Lek 2005;133:7-13.
87 Mrabet H,Belhedi N,Bouchlaka S.GEFS+ is not related to the most common mutations of SCN1B,SCN1A and GABRG2 in two Tunisian families.Neurol Sci 2007;28:311-314.
88 Audenaert D,Claes L,Claeys KG,et al.A novel susceptibility locus at 2p24 for generalized epilepsy with febrile seizures plus.J Med Genet.2005;42(12):947-952.
89 Baulac S,Gourfinkel-An I,Couarch P,et al.A Novel Locus for Generalized Epilepsy With Febrile Seizures Plus in French Families.Arch Neurol 2008;65:943-951.
90 Malacarne M,Madia F,Gennaro E.Lack of SCN1A Mutations in Familial Febrile Seizures.Epilepsia 2002;43:559-562.
91 Dibbens LM,Feng HJ,Richards MC,et al.GABRD encoding a protein for extra or perisynaptic GABAA receptors is a susceptibility locus for generalised epilepsies.Hum Mol Genet 2004;13:1315-1319.
92 Ma S,Abou-Khalil B,Blair MA,et al.Mutations in GABRA1,GABRA5,GABRG2 and GABRD receptor genes are not a major factor in the pathogenesis of familial focal epilepsy preceded by febrile seizures.Neuroscience Letters 2006;394:74-78.
93 Nakayama J.Progress in searching for the febrile seizure susceptibility genes.Brain & Development 2009 Feb 6.[Epub ahead of print].
94 Audenaert D,Broeckhoven CV,Jonghe PD.Genes and Loci Involved in Febrile Seizures and Related Epilepsy Syndromes.Human Mutation 2006;27,391-401.
95 Baulac S,Gourfinkel-An I,Nabbout R,et al.Fever,genes,and epilepsy.Lancet Neurol 2004;3:421-30.
96 Morimoto M,Mazaki E,Nishimura A,Chiyonobu T,Sawai Y,Murakami A,et al.SCN1A mutation mosaicism in a family with severe myoclonic epilepsy in infancy.Epilepsia 2006;47:1732-6.
97 Depienne C,Arzimanoglou A,Trouillard O,Fedirko E,Baulac S,Saint-Martin C,et al.Parental mosaicism can cause recurrent transmission of SCN1A mutations associated with severe myoclonic epilepsy of infancy.Hum Mutat 2006;27:389.
98 Nabbout A,Kozlovski A,Gennaro E.Absence of mutations in major GEFS+ genes in myoclonic astatic epilepsy.Epilepsy Research 2003;56:127-133.
99 Ohmori I,Ouchida M,Ohtsuka Y,et al..Significant correlation of the SCN1A mutations and severe myoclonic epilepsy in infancy.B.B.R.C.2002;295:17-23.
100 Harkin LA,.McMahon JM,Iona X.The spectrum of SCNIA-related infantile epileptic encephalopathies.Brain 2007;130:843-852.
101 Depondt C,Van Paesschen W,Matthijs G,Legius E,Martens K,Demaerel P,Wilms G.Familial temporal lobe epilepsy with febrile seizures.Neurology 2002;58:1429-33.
102 Berkovic SF,Mcintosh A,Howell RA,et al.Familial temporal lobe epilepsy:a common disorder identified in twins.Ann Neurol 1996;40:227-235.
103 Striano P,Gambardella A,Coppola A.Familial mesial temporal lobe epilepsy (FMTLE)A clinical and genetic study of 15 Italian families.J neurol 2008 Jan;255:16-23
104 Kanai K,Hirose S,Oguni H.Effect of localization of missense mutations in SCN1A on epilepsy phenotype severity.Neurology 2004;63:329-334.
105 Deng YH,Berkovic SF,Scheffer IE.GEFS+ where focal seizures evolve from generalized spike wave:video-EEG study of two children.Epileptic Disord 2007;9:307-14.
106 Ito M,Ohmori I,Nakahori T,et al.Mutation screen of GABRAl,GABRB2 and GABRG2 genes in Japanese patients with absence seizures
107 Sigel E,Buhr A.The benzodiazepine binding site of GABA,receptors.TiPS 1997;18:425-429.
108 Schweizer C,Balsiger S,Bluethmann H.The V 2 subunit of GABAA receptors is required for maintenance of receptors at mature synapses.Molecular and Cellular Neuroscience 2003;24:442-450.
109 Berezhnoy D,Nyfeler Y,Gonthier A.On the benzodiazepine binding pocket in GABA_A receptors.J bio chem 2004;279:3160-3168.
1.中华医学会.临床诊疗指南癫痫病分册.北京:人民卫生出版社,2007,118.
2.Fisher RS,van Erode Boas W,Blume W,et al.Epileptic seizures and epilepsy.Definitions proposed by the International League against Epilepsy(ILAE) and the International Bureau for Epilepsy(IBE).Epilepsia 2005;46:470-2.
3.Leone M,Beghi E.Epilepsy and quality of life inadults:A review of instruments.Epilepsia 2005;66:23-44.
4.Baker C.Assessment of Quality of Life in people with epilepsy:Some practical implications.Epilepsia 2001;42(Suppl.3):66-69.
5.Cowan J,Baker C.A review of subjective impact measures for use with children and adolescents with epilepsy.Quality of Life Research 2004;13:1435-1443.
6.Ronen GM,Streiner DL,Rosenbaum P.Health-related quality of life in children with epilepsy:Development and validation of self-report and parent proxy measures.Epilepsia 2003;44(4):598-612.
7.Sabaz M,et al.Validation of a new quality of life measure for children with epilepsy.Epilepsia 2000;41(6):765-774.
8.Cramer JA,Westbrook L,Devinsky O,Perrine K,Glassman M,Camfield C.Development of the quality of life in epilepsy inventory for adolescents:the QOLIE-AD-48.Epilepsia 1999;40:1114-21.
9.Benavente-Aguilar A,Morales C,Rubio E.Adaptacion transcultural delcuestionario de medida de calidad de vida (QOLIE-AD-48)en adolescentes epilepticos.Psiquis 2002;23:226-37.
10.Stevanovic D,Lozanovic-Miladinovic D,Jovic N,Sarenac M.The Serbian QOLIEAD-48:translation,cultural adaptation,and preliminary psychometric evaluation.Epilepsy Behav 2005;7:240-5.
11.Barbosa FD,Guerreiro MM,Pedroso de Souza EA.The Brazilian version of the Quality of Life in Epilepsy Inventory for Adolescents:Translation,validity,and reliability.Epilepsy Behav 2008;13:218-22.
12.Devinsky O,Westbrook L,Cramer J,Glassman M,Perrine K,Camfield C.Risk Factors for Poor Health-Related Quality of Life in Adolescents with Epilepsy.Epilepsia 1999;40:1715-20.
13.Benavente-Aguilar I,Morales-Blanquez C,Rubio EA,Rey JM.Quality of life of adolescents suffering from epilepsy living in the community.J Paediatr Child Health.2004;40:110-3.
14.Ficker DM,Privitera M,Krauss G,Kanner A,Moore JL,Glauser T.Improved tolerability and efficacy in epilepsy patients with extended-release carbamazepine.Neurology 2005;65:593-5.
15.Stevanovic D.Health-related quality of life in adolescents with well-controlled epilepsy.Epilepsy Behav 2007;10:571-5.
16.Jakovljevic MB,Jankovic SM,Jankovic SV,Todorovic N.Inverse correlation of valproic acid serum concentrations and quality of life in adolescents with epilepsy.Epilepsy Res 2008;80:180-3.
17.Chassany O,Sagnier P,Marquis P,Fullerton S,Aaronson N.Patient-reported outcomes:the example of health-related quality of life—a European guideline document for the improved integration of health-related quality of life assessment in the drug regulatory process.Drug Inf J 2002;36:209-38.
18.Bonett,Douglas..Sample Size Requirements for Testing and Estimating Coefficient Alpha.Journal of Educational and Behavioral Statistics 2002;27:335-340.
19.Walter SD,Eliasziw M,Dormer A.Sample size and optimal designs for reliability studies.Statistics in Medicine 1998;17:101-110.
20.Osborne,Jason & Anna B.Costello.Best practices in exploratory factor analysis:four recommendations for getting the most from your analysis.Practical Assessment Research & Evaluation 2005;10(7).Available online:http://pareonline.net/getvn.asp?v=10&n=7.
21.Kazis LE,Anderson JJ,Meenan RF.Effect sizes for interpreting changes in health status.Med Care.1989;27(Suppl.3):S178-S189.
22.Cull A,Sprangers M,Bjordal K,on behalf of the EORTC Quality of Life Group.EORTC Quality of Life Group translation procedure.Brussels:EORTC Publications,2002.
23.Varni JW,Seid M,Kurtin PS.PedsQLTM 4.0:reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations.Medical Care,2001;39:800-812.
24.Varni JW,Seid M,Knight TS,Uzark K,Szer IS.The PedsQLTM4.0 Generic Core Scales:sensitivity,responsiveness,and impact on clinical decision-making.Journal of Behavioral Medicine 2002;25:175-193.
25.Varni JW,Burwinkle TM,Seid M,Skarr D.The PedsQLTM 4.0 as a pediatric population health measure:feasibility,reliability,and validity.Ambulatory Pediatrics 2003;3:329-341.
26.Varni JW,Seid M,Kurtin PS.PedsQL~(TM)4.0:reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations.Medical Care,2001;39:800-812.
27.Chan KS,Mangione-Smith R,Burwinkl TM,Rosen M,Varni JW.The PedsQL~(?):reliability and validity of the short-form generic core scales and Asthma Module.Medical Care 2005;43,256-265.
28.Varni JW,Seid M,Kurtin PS.PedsQL~(?)4.0:reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations.Medical Care,2001;39:800-812.
29.Acquadro C,Conway K,Hareendran A,Aaronson N;European Regulatory Issues and Quality of Life Assessment (ERIQA)Group.Literature Review of Methods to Translate Health-Related Quality of Life Questionnaires for Use in Multinational Clinical Trials.Value Health.2008;11:509-21.
30.Andresen EM.Criteria for Assessing the Tools of Disability Outcomes Research.Arch Phys Med Rehabil 2000;81(Suppl 2):15-20.
31.Yam WK,Ronen GM,Cherk SW,et aL Health-related quality of life of children with epilepsy in Hong Kong:How does it compare with that of youth with epilepsy in Canada? Epilepsy Behav 2008;12:419-426.
32.Yam WK,Ma DK,Cherk SW;Working Group for Multi-Centre Study on Quality of Life Measures for Youth with Epilepsy.Factor structure and construct validity of the Chinese health-related quality of life measure for youth with epilepsy.Epilepsy Behav 2006;9:606-618.
33.Fong CY,Hung A.Public awareness,attitude,and understanding of epilepsy in Hong Kong Special Administrative Region,China.Epilepsia 2002;43:311-6.
34.Lai CW,Huang XS,Lai YH,Zhang ZQ,Liu GJ,Yang MZ.Survey of public awareness,understanding,and attitudes toward epilepsy in Henan province,China.Epilepsia 1990;31:182-7.
35.Chung MY,Chang YC,Lai YH,Lai CW.Survey of public awareness,understanding,and attitudes toward epilepsy in Taiwan.Epilepsia 1995;36:488-93.
36.Jacoby A,Snape D,Baker GA.Epilepsy and social identity:the stigma of a chronic neurological disorder.Lancet Neurol 2005;4:171-8.
37.Kwan P,Sander JW.History of Epilepsy in Chinese Traditional Medicine.J Neurol Neurosurg Psychiatry 2004;75(10):1376-81.
38.MacLeod JS,Austin JK.Stigma in the lives of adolescents with epilepsy:a review of the literature.Epilepsy Behav 2003;4:112-7.
39.Cowan J,Baker GA.A review of subjective impact measures for use with children and adolescents with epilepsy.Qual Life Res 2004;13:1435-43.
40.Terwee CB,Dekker FW,Wiersinga WM,et al.On assessing responsiveness of health-related quality of life instruments:Guidelines for instrument evaluation.Quality of Life Research 2003;12:349-362.
41.Wang M,Wu La,Zheng Y,et al.The Chinese QOLIE-AD-48:Translation,validity,and reliability.Epilepsy Behav 2009;14:476-80. Engel Jr.J.Report of the ILAE Classification Core Group.Epilepsia,2006;47:1558-t58.
2 Scheffer I,Berkovic S.Generalized(genetic) epilepsy with febrile seizures plus.In:Engel JJ,Pedley T,editors.Epilepsy:a comprehensive textbook.Philadelphia:Lippincott,Williams & Wilkins;2008.p.2553-8.
3 Ingrid E.Scheffer,Yue-Hua Zhang,Floor E.Jansen,et al.Dravet syndrome or genetic (generalized)epilepsy with febrile seizures plus? Brain & Development.Onlie.
4 Dube CM,Brewster AL,Richichi C,et al.Fever,febrile seizures and epilepsy.Trends Neurosci 2007;30:490-496.
5 Baulac S,Gourfinkel-An I,Nabbout R,et al.Fever,genes,and epilepsy.Lancet Neurol 2004;3:421-30.
6 Sadleir LG,Scheffer IE.Febrile seizures.BMJ 2007;334;307-311.
7 Fetveit A.Assessment of febrile seizures in children.Eur J Pediatr 2008;1671:17-27.
8 Wallace RH,Berkovic SF,Howell RA,et al.Suggestion of a major gene for familial febrile convulsions mapping to 8q13-21.J Med Genet 1996;33:308-312.
9 Johnson EW,Dubovsky J,Rich SS,et al.Evidence for a novel gene for familial febrile convulsions,FEB2,linked to chromosome 19p in an extended family from the Midwest.Hum Mol Genet 1998;7:63-67.
10 Peiffer A,Thompson J,Charlier C,et al.A locus for febrile seizures (FEB3)maps to chromosome 2q23±24.Ann Neurol 1999;46:671-8.
11 Mantegazza M,Gambardella A,Rusconi R,et al.Identification of an Nav1.1 sodium channel (SCN1A)loss-offunction mutation associated with familial simple febrile seizures.Proc Natl Acad Sci 2005;102:18177-18182.
12 Colosimo E,Gambardella A,Mantegazza M,et al.Electroclinical Features of a Family with Simple Febrile Seizures and Temporal Lobe Epilepsy Associated with SCN1A Loss-of-function Mutation.Epilepsia 2007;48:1691-1696.
13 Nakayama J,Hamano K,Iwasaki N,et al.Significant evidence for linkage of febrile seizures to chromosome 5q14-q15.Hum Mol Genet 2000;9:87-91.
14 Nakayama J,Fu YH,Clark AM,et al.A nonsense mutation of the MASS1 gene in a family with febrile and afebrile seizures.Ann Neurol 2002;52:654-657
15 Deprez L,Claes LR,Claeys KG,et al.Genome-wide linkage of febrile seizures and epilepsy to the FEB4 locus at 5q14.3-q23.1 and no MASS1 mutation.Hum Genet 2006;118:618-625.
16 Nabbout R,Prud'homme JF,Herman A,et al.A locus for simple pure febrile seizures maps to chromosome 6q22-q24.Brain 2002;125:2668-2680.
17 Nakayama J,Yamamoto N,Hamano K,et al.Linkage and association of febrile seizures to the IMPA2 gene on human chromosome 18.Neurology 2004;63:1803-1807.
18 Hedera P,Ma S,Blair MA,et al.Identification of a novel locus for febrile seizures and epilepsy on chromosome 21q22.Epilepsia 2006;47:1622-1628.
19 Audenaert,D,Schwartz E,Claeys KG,et al.(2006)A novel GABRG2 mutation associated with febrile seizures.Neurology 67,687-690.
20 Nabbout R,Baulac S,Desguerre I,et al.New locus for febrile seizures with absence epilepsy on 3p and a possible modifier gene on 18p.Neurology 2007;68;1374-1381.
21 Dai X,Chen W,Wang X,et al.A novel genetic locus for familial febrile seizures and epilepsy on chromosome 3q26.2-q26.33.Hum Genet 2008;124:423-429.
22 Hindocha N,NabboutR,Elmslie F.A case report of a family with overlapping features of autosomal dominant febrile seizures and GEFS+.Epilepsia Online.
23 SchefferIE,Berkovic SF.Generalised epilepsy with febrile seizures plus-a genetic disorder with heterogeneous clinical phenotypes.Brain 1997;120,479-490.
24 Singh R,Scheffer IE,Crossland K,et al.Generalized epilepsy with febrile seizures plus (GEFS1):a common,childhood-onset,genetic epilepsy syndrome.Ann Neuro 1999;145:75-81.
25 Engel J Jr.A proposed diagnostic scheme for people with epileptic seizures and with epilepsy:Report of the ILAE task force on classification and terminology.Epilepsia,2001,42:796-803.
26 Wallace RH,Wang DW,Sing R,et al.Febrile seizures and generalized epilepsy associated with a mutation in the Nal-channel b1 subunit gene SCN1B.Nat Genet 1998;19:366-370.
27 Meadows LS,Malhotra J,LoukasA,et al.Functional and Biochemical Analysis of a Sodium Channel _1 Subunit Mutation Responsible for Generalized Epilepsy with Febrile Seizures Plus Type 1.J Neurosci 2002;22:10699-10709.
28 Audenaert D,Claes L,Ceulemans B,et al.A deletion in SCN1B is associated with febrile seizures and early-onset absence epilepsy.Neurology 2003;61:854-6.
29 Wallace R,Scheffer IE,Parasivam G,et al.Generalised epilepsy with febrile seizures plus:mutation of the sodium channel subunit SCN1B.Neurology 2002;58:1426-9.
30 Scheffer IE,Harkin LA,Grinton BE,et al.Temporal lobe epilepsy and GEFS+ phenotypes associated with SCN1B mutations.Brain 2007;130:100-109.
31 Lossin C.A catalog of SCN1A variants.Brain Dev 2009;312:114-30.
32 Baulac S,Gourfinkel-An I,Picard F,et al.A second locus for familial generalized epilepsy with febrile seizures plus maps to chromosome 2q21-q33.Am J Hum Genet 1999;65:1078-85.
33 Moulard B,Guipponi M,Chaigne D,et al.Identification of a new locus for generalized epilepsy with febrile seizures plus (GEFS+)on chromosome 2q24-q33.Am J Hum Genet 1999;65:1396-400.
34 Lopes-Cendes I,Scheffer I E,Berkovic SF,et al.A New Locus for Generalized Epilepsy with Febrile Seizures Plus Maps to Chromosome 2.Am J Hum Genet 2000;6(5:698-701.
35 Escayg A,MacDonald BT,Meisler MH,et al.Mutations of SCNIA,encoding a neuronal sodium channel,in two families with GEFS+2.Nat Genet 2000;24:343-5.
36 Escayg A,Heils A,MacDonald BT,et al.A novel SCNIA mutation associated with generalized epilepsy with febrile seizures plus and prevalence of variants in patients with epilepsy.Am J Hum Genet 2001;68:866-73.
37 Wallace RH,Scheffer IE,Barnett S,et al.Neuronal sodium-channel alpha 1-subunit mutations in generalized epilepsy with febrile seizures plus.Am J Hum Genet 2001;68:859-65.
38 Abou-Khalil B,Ge Q,Desai R,et al.Partial and generalized epilepsy with febrile seizures plus and a novel SCNIA mutation.Neurology 2001;57:2265-72.
39 Annesi G,Gambardella A,Carrideo S,et al.Two novel SCNIA missense mutations in generalized epilepsy with febrile seizures plus.Epilepsia 2003;44:1257-8.
40 Lossin C,Rhodes TH,Desai RR,et al.Epilepsy-associated dysfunction in the voltage-gated neuronal sodium channel SCNIA.J Neurosci 2003;23:11289-95.
41 Spampanato J,Kearney JA,de Haan G,et al.A novel epilepsy mutation in the sodium channel SCN1A identifies a cytoplasmic domain for beta subunit interaction.J Neurosci 2004;24:10022-34.
42 Pineda-Trujillo N,Carrizosa J,Cornejo W,et al.A novel SCNIA mutation associated with severe GEFS+in a large South American pedigree.Seizure 2005;14:123-8.
43 Barela AJ,Waddy SP,Lickfett JG,et al.An epilepsy mutation in the sodium channel SCN1A that decreases channel excitability.J Neurosci 2006;26:2714-23.
44 Selmer KK,Egeland T,Solaas MH et al.Genetic screening of Scandinavian families with febrile seizures and epilepsy or GEFS+.Acta Neurol Scand 2008;117:289-92.
45 Marini C,Mei D,Temudo T,Ferrari AR,Buti D,Dravet C,et al.Idiopathic epilepsies with seizures precipitated by fever and SCNIA abnormalities.Epilepsia 2007;48:1678-85.
46 Sun H,Zhang Y,Liang J,et al.SCNIA,SCNIB,and GABRG2 gene mutation analysis in Chinese families with generalized epilepsy with febrile seizures plus.J Hum Genet 2008;53:769-74.
47 ZuccaC,Redaelli F,EpifanioR,et al.Cryptogenic Epileptic Syndromes Related to SCN1A.Arch Neuro.2008;65(4):489-494.
48 Lossin C,Wang DW,Rhodes TH,et al.Molecular basis of an inherited epilepsy.Neuron 2002;34:877-884.
49 Spampanato J,Escayg A,MeislerMH,et al.Functional effects of two voltage-gated sodium channel mutations that cause generalized epilepsy with febrile seizures plus type 2.J Neurosci 2001;21,7481-7490.
50 Spampanato J,Escayg A,Meisler MH,et al.Generalized epilepsy with febrile seizures plus type 2mutation W1204R alters voltage-dependent gating of Nav1.1 sodium channels.Neuroscience 2003;116,37-48.
51 Ragsdale DS.How do mutant Navl.l sodium channels cause epilepsy? Brain Res Rev.2008;581:149-59.
52 Lossin C,Rhodes TH,Desai RR,et al.Epilepsy-associated dysfunction in the voltage-gated neuronal sodium channel SCN1A.J Neurosci 2003;23,11289-11295.
53 Ohunori I,Ouchida M,Ohtsuka Y,et al.Significant correlation of the SCN1A mutations and severe myoclonic epilepsy in infancy.Biochem Biophys Res Commun 2002;295(1):17-23.
54 Ceulemans BP,Claes LR,Lagae LG.Clinical correlations of mutations in the SCN1A gene:from febrile seizures to severe myoclonic epilepsy in infancy.Pediatr neurol 2004;30:236-243.
55 Kanai K,Hirose S,Oguni H,et al.Effect of localization of missense mutations in SCN1A on epilepsy phenotype severity.Neurology 2004;63:329-334.
56 Baulac S,Huberfeld G,Gourfinkel AnI,et al.First Genetic evidence of GABA(A)receptor dysfunction in epilepsy:a mutation in the gamma2 subunit gene.Nat Genet2001;28:46-48.
57 Wallace RH,Marini C,Petrou S,et al.Mutant GABAA receptor gamma2 subunit in childhood absence epilepsy and febrile seizures.Nat Genet,2001;28(1):49-52.
58 Harkin LA,Bowser DN,Dibbens LM,et al.Truncation of the GABAA receptor c2-subunit in a family with generalized epilepsy with febrile seizures plus.Am J Hum Genet 2002;70:530-536.
59 Kanainura C,Haug K,Sander T,et al.A splice-site mutation in GABRG2 associated with childhood absence epilepsy and febrile convulsions.Arch Neurol 2002;59:1137-1141.
60 Sugawara T,Tsurubuchi Y,Agarwala KL,et al.A missense mutation of the Na+channel alpha II subunit gene Nav1.2 in a patient with febrile and afebrile seizures causes channel dysfunction.Proc Natl Acad Sci USA 2001;98:6384-6389.
61 Dibbens LM,Feng HJ,Richards MC,et al.GABRD encoding a protein for extra or perisynaptic GABAA receptors is a susceptibility locus for generalised epilepsies.Hum Mol Genet 2004;13:1315-1319.
62 Hua-Jun Feng,1 Jing-Qiong Kang,1 Luyan Song,δ Subunit Susceptibility Variants E177A and R220H Associated with Complex Epilepsy Alter Channel Gating and Surface Expression of α4β2δ GABAA Receptors.J Neurosci 2006;26:1499-1506.
63 Audenaert D,Claes L,Claeys KG,et al.A novel susceptibility locus at 2p24 for generalized epilepsy with febrile seizures plus.J Med Genet.2005;42(12):947-952.
64 Baulac S,Gourfinkel-An I,Couarch P,et al.A Novel Locus for Generalized Epilepsy With Febrile Seizures Plus in French Families.Arch Neurol 2008;65:943-951.
65 Sugawara T,Mazaki-Miyazaki E,Ito M,et al.Nav1.1 mutations cause febrile seizres associated with afebrile partial seizures.Neurology 2001;57:703-5.
66 Liao WP,Shi YW,Qin B.Partial epilepsy with febrile seizure plus:A subtype of GEFS+ or SME? Neurology Asia 2007;12(Supplement 1):78-79.
67 陈俐,石奕武,邓维意.部分性痫伴热性惊厥附加症家系中的SCNlA基因嵌合突变.中华神经科杂志2008;41:580-584.
68 Kumakura A,Ito M,Hata D,et al.Novel de novo splice-site mutation of SCN1A in a patient with partial epilepsy with febrile seizures plus.Brain Dev 2009;31:179-82.
69 Baulac S,Picard F,Herman A,et al.Evidence for digenic inheritance in a family with both febrile convulsions and temporal lobe epilepsy implicating chromosomes 18qter and 1q25- q31.Ann Neurol 2001;49:786-792.
70 Depondt C,Van Paesschen W,Matthijs G,Legius E,Martens K,Demaerel P,Wilms G.Familial temporal lobe epilepsy with febrile seizures.Neurology 2002;58:14129-33.
71 Claes L,Audenaert D,Deprez L,et al.Novel locus on chromosome 12q22-q23.3responsible for familial temporal lobe epilepsy associated with febrile seizures.J Med Genet 2004;41:710-4.
72 Lenzen KP,Heils A,LorenzS,et al.Association analysis of the Arg220His variation of the human gene encoding the GABAδ subunit with idiopathic generalized epilepsy.Epilepsy Res 2005;65:53-57.
73 孟海娇,洪震,朱国行.GABRG2基因多态性在GEFS+中分布的研究.神经疾病与 精神卫生 2003；3：411-416．
74 Chou IC,Peng C,Huang CC,et al.Association analysis of gamma 2 subunit of gamma amino butyric acid type A receptor polymorphisms with febrile seizures Pediat Res 2003;54:26-29.
75 Kiinirons P,Cavalleri GL,Shahwan A.Examining the role of common genetic variation in the y2 subunit of the GABAA receptor in epilepsy using tagging SNPs.Epilepsy Res 2006;70:229-38.
76 Xiumin Wang,Meichun Xu,Lizhong Du/ Association Analysis of γ2 Subunit of γ-aminobutyric Acid (GABA)Type A Receptor and Voltage-gated Sodium Channel Type Ⅱ a-polypeptide Gene Mutation in Southern Chinese Children With Febrile Seizures.J Child Neurol 2007;22:714-9.
77 Ma S,Abou-Khalil B,Sutcliffe JS,et al.The GABBR1 locus and the G1465A variant is not associated with temporal lobe epilepsy preceded by febrile seizures.BMC Med Genet 2005;6:13.
78 Chou IC,Peng CT,Tsai FJ,et al.The lack of association between febrile convulsions and polymorphisms in SCN1 A.Epilepsy Res 2003;54:53-7.
79 Nakayama K,Yamamoto N,Hamano K,et al.Failure to find evidence for association between voltage-gated sodium channel gene SCN2A variants and febrile seizures in humans.Neuroscience Letters 2002;329:249-251.
80 Haspolat S,Baysal Y,Duman O,et al.Interleukin-1α,Interleukin-1β,and Interleukin-IRa Polymorphisms in Febrile Seizures.J Child Neurol 2005;20:565-8.
81 Kanemoto K,Kawasaki J,Miyamoto T,et al.Interleukin (IL)lbeta,IL-1 alpha,and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy.Ann.Neurol 2000;47:571-574.
82 Virta M,Hurme M,Helminen M.Increased frequency of inter leukin-1 beta (-511)allele 2 in febrile seizures.Pediatr Neurol 2002;26:192-195.
83 Kira R,Torisu H,TakemotoM,et al.Genetic susceptibility to simple febrile seizures:interleukin-1beta promoter polymorphisms are associated with sporadic cases.Neurosci Lett 2005;384:239-244.
84 Tilgen N,Pfeiffer H,Cobilanschi J,et al.Association analysis between the human interleukin 1beta (-511)gene polymorphism and susceptibility to febrile convulsions.Neurosci Lett 2002;334:68-70.
85 Tsai FJ,Hsieh YY,Chang CC,et al.Polymorphisms for interleukin 1 beta exon 5 and interleukin 1 receptor antagonist in Taiwanese children with febrile convulsions.Arch.Pediatr.Adolesc Med 2002;156:545-548.
86 Nakayama J,Arinami T.Molecular genetics of febrile seizures.Epilepsy Res 2006;70:190-198.
87 Tsai FJ,Chou IC,Hsieh YY,et al.Interleukin-4 Intron 3 Polymorphism is Not Related to Suscelptibility to Febrile Seizures.Pediatr Neurol 2002;27:271-4.
88 Chou IC,Lee CC,Huang CC,et al.Association of the neuronal nicotinic acetylcholine receptor subunit alpha4 polymorphisms with febrile convulsions.Epilepsia 2003;44:1089-1093.
89 Mulley J,Heron S,Schefier I,et al.Febrile convulsions and genetic susceptibility:role of the neuronal nicotinic acetylcholine receptor aIpha 4 subunit.Epilepsia 2004;45:561.
90 马祎楠,陈志越,邹丽萍等.单纯性家族性热性惊厥与HCN2基因的相关研究.中华医学杂志2005:85:661-665.
91 Ma Y,Qi Y,Chen Z,et al.Polymorphisms of casein kinase I gamma 2 gene associated with simple febrile seizures in Chinese Han population.Neurosci Lett 2004;368:2-6.
92 Lin LC,Lin HS,Yang RC.Neuropeptide Y gene polymorphism and plasma neuropeptide Y level in febrile seizure patients in Taiwan.Kaohsiung J Med Sci 2007;23:560-5.
93 Kang HJ,Choi KO,Kim BD,et al.FESD:a Functional Element SNPs Database in human.Nucleic Acids Res 2005;33(Database issue):D518-22.
94 Dub(?) C,Richichi C,Bender RA,et al.Temporal lobe epilepsy aider experimental prolonged febrile seizures:prospective analysis.Brain 2006;129:911-22.
95 Toth Z,Yan XX,Haftoglou S,et al.Seizure-induced neuronal injury:vulnerability to febrile seizures in an immature rat model.J Neurosci 1998;18:4285-4294.
96 Jiang W,Duong TM,de Lanerolle NC,et al.The neuropathology of hyperthermic seizures in the rat.Epilepsia 1999;40:5-19.
97 Lemmens EM,Lubbers T,Schijns OE,et al.Gender differences in febrile seizure induced proliferation and survival in the rat dentate gyrus.Epilepsia 2005;46:1603-1612.
98 Chang YC,Huang AM,Kuo YM,et al.Febrile seizures impair memory and cAMP response element binding protein activation.Ann.Neuro12003;4:706-718.
99 Bender RA,Dub6 C,Gortzalez-Vega R,et al.Mossy fiber plasticity and enhanced hippocampal excitability,without hippoeampal cell loss or altered neurogenesis,in an animal model of prolonged febrile seizures.Hippocampus 2003;13:357-370.
100 Jansen JF,Lemmens EM,Strijkers G J,et al.Short- and long-term limbic abnormalities after experimental febrile seizures.Neurobiol Dis 2008;32:293-301.
101 Van Landingham KE,Heinz ER,Cavazos JE,et al.Magnetic resonance imaging evidence of hippocampal injury after prolonged focal febrile convulsions.Ann.Neurol 1998;43:413-426.
102 Scott RC,Gadian DG,King MD,et al.Magnetic resonance imaging findings within 5 days of status epilepticus in childhood.Brain 2002;125:1951-1959.
103 Scott RC,King MD,Gadian DG,et al.Hippocampal abnormalities after prolonged febrile convulsion:a longitudinal MRI study.Brain 2003;126:2551-2557.
104 Houser CR.Granule cell dispersion in the dentate gyrus of humans with temporal lobe epilepsy.Brain Res 1990;535:195-204.
105 Dube C,Yu H,Nalcioglu O,et al.Serial MRI after experimental febrile seizures:altered T2 signal without neuronal death.Ann.Neurol 2004;56:709-714.
106 Natsume J,Bernasconi N,Miyauchi M,et al.Hippocampal volumes and diffusion-weighted image findings in children with prolonged febrile seizures.Acta Neurol Scand 2007;115:25-28.
107 Tarkka R,Paakko E,Pyhtinen J,et al.Febrile seizures and mesial temporal sclerosis-No association in a long-term follow-up study.Neurology 2003;60:215-8.
108 Auer T,Barsi P,Bone B,et al.History of simple febrile seizures is associated with hippocampal abnormalities in adults.Epilepsia 2008;49:1562-9.
109 Chang YC,Huang CC,Huang SC.Long-term neuroplasticity effects of febrile seizures in the developing brain.Chang Gung Med J 2008;31:125-35.
110 Cendes F.Febrile seizures and mesial temporal sclerosis.Curr Opin Neurol.2004;17:161-4.
111 Shinnar S.Febrile seizures and mesial temporal sclerosis.Epilepsy Curr 2003;3:115-118.